SlideShare ist ein Scribd-Unternehmen logo
1 von 174
The sign wasn’t placed there
                 By the Big Printer in the sky


        Management of Stroke
         ( Three to Twenty Four Hours )
Prof.A.V.Srinivasan , M D, DM, Ph.D, DSc,F.R.C.P.(London)
                      F.A.A.N, F.I.A.N
                   Emeritus Professor,
           The   Tamilnadu Dr.M.G.R.Medical university
                   Former Professor and Head ,
                   INSTITUTE OF NEUROLOGY
                   Madras Medical Colege
OBJECTIVE
   Definition
   Stroke burden
   Types & Mechanisms
   Risk factors
   Clinical evaluation
   Investigations
   Treatment of ischaemic stroke
   Treatment of h hemorrhagic stroke & SAH
   Rehabilitation
   Newer developments – Interventions & neuroprotectives.
Stroke: WHO Definition
   Stroke is clinically defined as a neurologic
syndrome characterized by “Rapidly developing
     clinical signs of focal (at times global)
 disturbance of cerebral function, lasting more
   than 24 hours or leading to death with no
  apparent cause other than that of vascular
                      origin”.

 CONCEPT OF           “BRAIN ATTACK”
         In all of us, even in good men, there is a
        wild - beast nature which peers out in sleep
Burden of Stroke
   Most common life-threatening neurologic disease
   Third most common cause of death globally
   Incidence in India: 73/1,00,000 per year
   No formal registry available.
   Burden is likely to increase with risk factors like
    aging, smoking, adverse dietary patterns
   Most common cause of disability and
    dependence.
   70% of stroke survivors remaining vocationally
    impaired
   30% requiring assistance with daily activities
     The True Art of Memory is The Art of Attention
                                              - S.Johnson
Burden of Stroke

    26 per lac per year
    Ischaemic – 69%
    Hemorragic –23%
    SAH – 3%
    Undetermined – 5%


We learn by thinking and the quality of the learning outcome is
          determined by the quality of our thoughts
                                             R.B. Schmeck
Types & mechanisms
    Ischaemic – Atherothrombotic
                    Embolic
                    Lacunar
    Hemorrhagic – ICH
                          SAH
    Global hypoperfusion – Watershed
     infarcts.
A true commitment is a heart felt promise to yourself from which
                    you will not back down
                                        - D. Mcnally
Stroke: Classification

  Ischemic stroke: Account for 80%.
     Results from occlusion in the blood vessel
      supplying the brain
     Thrombotic: Occlusion due to
      atherothrombosis of small/large vessels
      supplying the brain
     Embolic: Occlusion due to embolus arising
      either from heart (e.g. atrial fibrillation,
      valvular disease) or blood vessel

Serious, sincere, systematic study surely secures supreme success
Classification (contd.)
Hemorrhagic stroke: Account for 20%. Results
  from rupture of blood vessels leading to
  bleeding in brain
   Intracerebral: Bleeding within the brain due
    to rupture of small blood vessels. Occurs
    mainly due to high blood pressure
   Subarachnoid: Bleeding around the brain;
    commonest cause is rupture of
    aneurysm.Other causes: Head injury

Habit is either the best of servants or worst of masters
LACUNAR INFARCT
   <10mm in size.
   Absence of cortical sings.
   Super lacune >15mm.
   Syndromes- ataxic hemiparesis
   pure motor, pure sensory,sensory-motor
   dysarthria clumsy hand, pure dysarthria,
   hemichorea& unilateral asterixis.

Success in life is a matter not so much of talent and opportunity
      as of concentration and perseverance - C.W. Wendte
LACUNAR INFARCT
       Associated with Systemic hypertension,
        DM
       Weight of the heart exceeds 400g.
       Prognosis -no mortality,
       lenticulo striate territory-good recovery
       ant.cho.artery-poor recovery.

Give us the GR  ACE to acce pt with se re nity the thing s that canno t be
chang e d the COUR  AGE to chang e the thing s that sho uld be chang e d
               and the WISDOM to kno w the diffe re nce
Oxfordshire Community Stroke
             project (OCSP)
   Anterior circulation stroke – Total
    (TACS)
   Anterior circulation stroke – Partial
    (PACS)
   Posterior circulation stroke – PCS
   Lacunar Strokes.- (LS)
“ He who cannot forgive others destroy the bridge over which he
                                      s
              him m pass”
                  self ust              - Annoy
Differentials
   Focal epilepsy.
   Migraine.
   Transient Global Amnesia.
   Tumor
   Metabolic Encephalopathy
   Multiple Sclerosis.

          The secret of walking on water is
            Knowing where the stones are
Transient Ischemic Attack (TIA)
   “Mini stroke”
   Stroke symptoms last for less than 24 hours
    (usually 10 to 15 mins)
   Result as a brief interruption in blood flow to
    brain
   Every TIA is an emergency
   TIA may be a warning sign of a larger stroke
   Patients with possible TIA should be evaluated
            If you think you can or you can’t
                  You are always right
TIA- contd
   Few minutes to 24hrs (>85% within
    30mts).
   12% atherosclerotic infarct
   Predominantly negative symptoms.
   Weakness/numbness of
    UL/UL&LL,speech disturbance,mono
    ocular blindness, weakness of
    thumb&index the daughter of attention ,
           Memory, finger.
     is the teeming mother of knowledge   - Martin Tupper
Stroke: Predisposing factors
   Age (risk doubles for every decade after
    55yrs)
   Gender (males>females)
   Family history of stroke/TIA
   Hypertension
   Diabetes
   Hyperlipidemia
   Hyperhomocysteinemia
             As long as you get there before
               It’s over you’re never late
Stroke: Predisposing factors
   Obesity
   Smoking
   Atrial fibrillation
   Sedentary lifestyle
   Drug abuse (e.g. cocaine use)
   Hormone replacement therapy
   Oral contraceptive

            Discipline Weighs ounces
             Regret weighs Tons
Genetics & stroke
   Single gene disorder
           Sickle cell disease
           Homocystinuria
           Marfans syndrome – dolichoectasia
           Fabry’s disease
   Vascular risk factors
           Genetic hypercoagulable disorders
           Metabolic disorders with vasculopathy
           Hereditary intracranial aneurysms
               Some people feel the rain;
                   Others just get wet
Genetics & stroke
   CADASIL – Cerebral Autosomal Dominant
    Arteriopathy with Subcortical infarcts and
    Leucoencephalopathy.
   Recurrent episodes of subcortical infarcts or
    TIAs
   Onset 30 – 50 years
   Stroke, dementia, pseudobulbar palsy,
    migraine
   MRI shows extensive leucoencephalopathy
     Opinion is ultimately determined by the feelings
                  and not by the intellect
Genetics & stroke
   Multiple infarcts in the basal ganglia
    and in the periventricular regions .
   U- fibers are spared.
   Skin biopsy is diagnostic- granular,
    eosinophilic, electron dense material in
    the media of the arterial wall.
   Familial clusters with hemiplegic
    migraine- CADASIL - M
            Experience can be defined as
        yesterday’s answer to today’s problems
Stroke: Symptoms
   Onset of stroke symptoms varies as per type
    of stroke


          Thrombotic stroke: Develop more
           gradually
          Embolic stroke: Hits suddenly
          Hemorrhagic stroke: Hits suddenly and
           continues to worsen
              It is the province of the knowledge to speak
         and it is the privilege of the wisdomto listen - Hodly’s
Stroke: Symptoms (contd.)
   Dizziness
   Confusion
   Loss of balance/coordination
   Nausea/vomiting
   Numbness/weakness on one side of the body
   Seizure
   Severe headache
   M ovement disorder/speech disorder/blindness etc
    (depending on the area of brain affected)
    Additional symptoms for hemorrhagic stroke
   Pain upon looking at or into light
   Painful stiff neck
“SILENT STROKES”

  A silent stroke is a stroke which causes
 brain damage, but does not exhibit classic
symptoms of stroke. They are detected only
 when a person undergoes a brain scan. –
              Multi infarct state.


        The meek shall inherit the earth
          - but not its mineral rights
Stroke management


“TIME
           IS
                       BRAIN”
 Our best thoughts come from others
Stroke management

   Detection
   Dispatch



    Door
    Data
                           6 Ds
   Decision
   Drug
               It’s not over until it’s over
DETECTION




  Success is a prize to be won. Action is the road to it.
Chance is what may lurk in the shadows at the road side.
                                                            - O. Henry
Stroke management - Detection
   Cincinatti stroke Score
            - Facial droop
            - Arm drift
            - Slurred speech


1 out of 3 - > 72% probability of stroke.
Thinking is the hardest work there is, which is probable reason
                    why so few engage in it.
                                                           - Henry Ford
Stroke management - Detection
   Los Angeles Probable stroke Score.
    (LAPSS)
   Includes arm drift, facial droop, slurring
    of spech, age , presence of risk factors
    like hypertension, DM, previous TIAs,
   Little cumbersome.
   No better than Cincinatti Score.
    People of mediocre ability often achieve success because
      they don’t know enough to quit - Bernard Baruch
DISPATCH


        TO HOSPITAL


                              EMR
 Whatever the Mind can conceive and Believe,
            the mind can Achieve
                               Napoleon Hill
Stroke management – to Door

   On suspicion of stroke the person
    should be dispatched to the
    Emergency Medical Room as early as
    possible.( Within minutes)
   Maintain vitals and arrange for
    transport.
   No Aspirin or heparin to be
    administered.
     “ Social Isolation is in itself a pathogenic
          Factor for disease production”
 DATA

   EMERGENCY IMAGING – CT/
  MRI
     BIOCHEMICAL PROFILE
     Possible investigations.

Science is below the mind; Spirituality is beyond the mind
Stroke management – Door to data
   Physical examination: Vitals,Neurologic
   Brain imaging (cranial CT and/or
    MRI): discriminate between ischemic
    and hemorrhagic
   Stroke Doppler ultrasonography/Angiography:
    Detect large vessel atherosclerosis
   ECG/Echocardiography: Detect cardiac
    embolism
   Exclusion of conditions mimicking stroke
    (hypoglycemia, migraine, seizure)
          Speak obligingly even if you cannot oblige
Ischemic stroke diagnostic algorithm

Acute focal brain deficit                                    Excluded hypoglycemia, migraine
                                                              with aura, post-seizure deficit



                              < 1 hour                        TIA (if CT/MR brain imaging
     Head CT                                                  without ischemic lesion)



   Ischemic Stroke

                                    Lacunar syndrome
     Cortical
     syndrome           Doppler               MRI          Vasculopathy             CRYPTOGENIC
                        MRA                   CT           Coagulopathy               STROKE
      ECG               Angiogram
      Echo

    CARDIAC         LARGE ARTERY             SMALL      OTHER DETERMINED
   EMBOLISM       ATHEROSCLEROSIS        VESSEL DISEASE      CAUSE

  A woman’s desire for revenge outlasts all her other emotions
General management
   ABC
   Fluids & electrolytes
   Dysphagia, aspiration
   Urinary dysfunction
   Venous thromboembolism
   Seizures
   Skin care
   Depression
          Maintaining the right attitude is easier than
              regaining the right mental attitude
Management of acute ischemic stroke
   Systemic thrombolysis:
   Intravenous recombinant tissue plasminogen
    activator (rt-PA)
   Within 3 hrs of onset of stroke.
   Dose 0.9 mg/kg, max 90 mg.
   Intra arterial thrombolysis is being tried.-
    time window is upto 6 hrs. – technically
    demanding.
No Aspirin or heparin for 24 hrs. following
 thrombolysis
When they tell you to grow up, they mean stop growing
Management of acute ischemic stroke
                     (contd..)
   Anticoagulants: Heparin/LMWH NOT
    recommended in acute ischemic stroke routinely.
   Recommended in setting of atrial fibrillation,
    acute MI risk, prosthetic valves, coagulopathies
    and for prevention of DVT.
   Intra-arterial thrombolytics: An option for
    treatment of selected patients with major stroke
    of < 6 hrs duration due to large vessel occlusion.
             Why should I question the monkey
           when I can question the organ grinder?
Management of acute ischemic stroke
           (contd)- hypertension
   BP Should be kept within higher normal limits
    since low BP could precipitate perfusion failure.
   Reduction of BP in acute stroke phase is
    controversial.
   Reduce BP if there is severe end organ damage
    like pulmonary edema, encephalopathy, uremia.
    Markedly elevated BP (>220/110mmHg) managed
    with nitroglycerin, clonidine, labetalol, sodium
    nitroprusside.
   More aggressive approach is taken if thrombolytic
    therapy is instituted
       He is free who knows how to keep in his own hands
                    the power to decide
Management of acute ischemic stroke
           Glucose & pyrexia
   Blood glucose Should be kept within
    physiological levels using oral or IV
    glucose (in case of hypoglycemia)
   insulin (in case of hyperglycemia) RBS
    >300 mg
   Avoid routine glucose infusions
   Elevated body temperature
    management: Antipyretics and use of
    cooling device can improve the
    prognosis
           To get to the promised land you have to
          negotiate your way through the wilderness
Specific therapy - Ischaemic
   Thrombolytic therapy- r- tPA
   Time window – 3 hrs.
   0.9 mg/kg max. 90mg.
   10% bolus & 90% as infusion in 1 hour.
   Risk of hemorrage – 6%


It is a great misfortune not to possess sufficient wit to speak well
               nor sufficient judgment to keep silent
                                                    La Broyers character
Ancrod
          Venom of Malaysian pit viper.
          ↓Fibrinogen & viscosity
          ↓ RBC aggregation
          Endogenous tPA upregulation
          Vasodilatation
          Anticoagulant activity.

We possess by nature the factors out of which personality can be made, and to organize them
             into effective personal life is every man’s primary responsibility
                                                                  - Harry Emerson Fosdick
Hemorrheologic therapy
   Hemodilution
   Pentoxyfylline
   Ancrod – Malaysian pit viper venom.



       Mind is the great level of all things;
     human thought is the process by which
      human ends are ultimately answered
Thrombolytic drugs
   t NK- Tenectoplase – derived from t
    PA.
   Desmoteplase
   Alteplase
   r- pro UK
   Gp IIIa Iib receptor blockers.
   Lys- plasminogen
        “ Social Isolation is in itself a pathogenic
             Factor for disease production”
Secondary prevention of stroke
   Recurrence: Annual risk is 4.5 to 6%.
   Five year recurrence rates range from 24 to 42%
   one-third occur within first 30 days, hence high
    priority should be given to secondary prevention.
   Patients with TIA or stroke have an increased risk
    of MI or vascular event.
   Management of hypertension (goal <140/85 mm Hg)

                 A bad teacher complains;
                  A good teacher explains;
                 The best teacher inspires;
Secondary prevention of stroke

   Diabetes control (goal<126 mg/dL)
   Lipid management: Statins (goal
    cholesterol<200 mg/dL, LDL<100
    mg/dL)
   Anticoagulants: Warfarin (target INR 2
    to 3); esp. recommended in patients
    with cardioembolic stroke
   Appropriate life style modification
    (cessation of smoking, exercise, diet
    etc) Knowledge without action is useless;
          Action without knowledge is foolish
Secondary prevention of stroke
           Antiplatelet agents:
   Aspirin (50-325 mg),
   clopidogrel (75 mg).
   Ticlopidine 200mg bid
   Aspirin + ER Dipyridamole
   Sulfinpyrazone
   Suloctidil
   A combination of the two drug may also be
    used
Reputation is made in a moment; character is built in a life time
Complications of stroke
   Cerebral edema – 30% of patients
    worsen after stroke due to cerebral
    edema.
   24 – 96 hrs after acute stroke.
   Initially cytotoxic(gray matter),later
    vasogenic (white matter)
   Excitatory amino acids (EAA) –
    produces neurotoxic edema –
          Vedanta admits realization
    accelarates apoptosis.
          But defies verbal definition
Complications of ischaemic stroke
   Hemorrhagic transformation occurs in about
    40%.
   Occurs in first 2 weeks.
   10% of patients worsen.
   Increased risk with antithrombotics,
    anticoagulants, and thrombolytic therapy.
   Size (>1/3 rd) of the vascular territory and
    elderly are more prone for hemorrhagic
    transformation.
            Pure love ever gives; Never seeks
Management of Acute hemorrhagic
                stroke
   Analgesics/Antianxiety agents: To relieve
    headache. Analgesics having sedative
    properties are beneficial
   Hyperosmotic agents (e.g. mannitol,
    glycerol, furosemide): To reduce cerebral
    edema, and raised intracranial pressure.
   Adequate hydration is necessary
   Surgical intervention may occasionally be
    life saving
              What is mind no matter
             What is matter never mind
Surgical interventions
   Balloon angioplasty/stenting
   Carotid endarterectomy/Bypass
   Decompressive craniectomy
   Stem cell therapy.




    Every thing should be made as simple as possible;
                     but not simpler
Carotid endarterectomy & stenting
   CEA in symptomatic patients provides
    protection against stroke. ( >70% stenosis)
   In 50 –69% stenosis the benefit is marginal
    compared to medical therapy.
   The stroke reduction is realized early after
    surgery and persisted for extended periods.
   In TIA CEA has to be performed as early as
    possible if there is significant stenosis
   ECST and NASCET trials have proved the
    benefit.
     Hate screeches, fear squeals; conceits trumpets
                but love since lullabies
Carotid stenting & angioplasty
    “ FROM KNIFE TO STENT”
   In patients having a increased surgical
    risk.
   CCF, severe COPD, unstable angina,
    past radiation therapy, local tumor
    mass etc.,.
   SAPPHIRE study has shown benefit in
    a group of patients.
   Angioguardadapt, adjust and accommodate device is
            Learn to emboli protection
    used. to give, not to take and learn to serve not to rule
      Learn
Sub arachnoid hemorrhage (SAH)
   Aneurysmal or non aneurysmal.
   Vasospasm is a critical factor.
   Autoregulation impaired with
    vasospasm.
   Hunt and Hess grading – Clinical
   Fisher grading – CT scan
   Lumbar puncture may be necessary.
Teachers are reservoirs from which, through the process of
      education, the students draw the water of life
SAH - TRIPLE - H Therapy
   Hypertension
   Hypervolemia
   Hemodilution
   Nimodipine – used to treat vasospasm.




Love is selfishness and selfishness is lovelessness
SAH - Surgical
   Aneurysmal clipping within 48 – 72
    hours
   Prevents early rebleeding
   Permits aggressive therapy for
    vasospasm
   Endovascular therapy – coiling with
    GDC coils or thrombogenic platinum
    coils
   Asymptomatic one who thinks to his> 6mm
          Expert is aneurysms -
              chosen mode of ignorance
GUIDELINES
History And Examination
                 Guide: 1 & 2
a.            Stroke clerking Performa (1994)
     R.C.P.
1.     Improved patient Assessment
2.      Improved Management & outcome- not
     clear


b.            Examination
1.     Secure Diagnosis of Stroke
2.     Specify Impairment
3. Identify sub type of Ischemic an audience
 God is a comedian performing before stroke
                that is afraid to laugh
Guide: 3               (B) - CPR

 –    Impaired consciousness in stroke is common in
     posterior circulation strokes.
 –     Impaired Consciousness - From Stroke
     Resuscitation is rarely successful -
     Schneider 1993




“Prediction is always difficult – especially when it concerns the future”
                                                    – Oscar Wilde
Guide: 4 - CXR

Chest x-ray abnormal in 16%
–    Only 4% change clinical management
–    Order x-ray chest if WT Loss or chest
    symptoms present
- Not recommended in routine stroke
   management.


If I were to choose between pain and nothing… I would choose pain
                                           -- William Faulkner
Guide: 5 - ECG
   Detection of cerebrogenic cardiovascular
    disturbance.
   Acute ST- T changes,rhythm abnormalities
    are common (upto 40%)
   Insular cortex involvement is an independent
    risk factor
   Rt. Sided lesions, age ,HT/DM/IHD are other
    factors
   Cardiac cause of Death (30 days)
   ALL STROKE PATIENTS TO HAVE ECG
    Pain is god’s greatest gift to mankind - Paul Brand.
Guide: 6 - ECHO
   To identify stroke mechanism.
   LV clot, Patent Foramen Ovale (PFO), Infective
    endocarditis, AF,Silent lesions
   Detects silent cardiac lesions
   Lesions of aorta
   TEE is more useful than TTE.
   High yield in ischaemic lesions.
   RECOMMENDED IN SETTINGS WHERE
    AVAILABLE and im oralityare two of the greatest inhibitors of
     The Truth is fear m
                        Performance to progress
Guide: 7 - CT scan brain
   ABSOLUTE INTEGRAL PART IN STROKE
   Differentiates between ischaemia, hemorrhage,
    SAH
   Early signs are useful in deciding about
    thrombolytic therapy. (Hyperdense MCA
    sign,insular ribbon sign,sulcal effacement)
   Helical and CT Angio are useful.
   MUST IN ALL STROKES
       Develop the heart; art comes automatically
Guide 8: M.R.I.

 Not   Routine in Acute Stroke
 Diffusion & perfusion weighted images are
 very useful in the acute phase in ischaemic
 infarction
 Along   with MRA gives valuable information
 NOT    ROUTINELY INDICATED

    “ My opinions are founded on knowledge
              but modified by experience”
Guide 9: - Doppler studies
   B-mode, Duplex, continuous wave and pulsed
    doppler systems, Color doppler flow imaging,
    TCD
   Shows changes in flow patterns near
    plaques.
   Gives idea about the vulnerability of the
    plaque.
   Useful in assessing the Vasospasm,
    collateral circulation, hemodynamic effects,
    reserve capacity
    To plan carotid endarterectomy.
   IUSEFUL peripheral neuritis– it interferes with work
      don’t like IN APPROPRIATE CLINICAL
Guide 10: (B) - FEVER
 Fever  (Worst Prog.) – 1 * C increases the
  metabolic need by 7% . Treatment of fever has
  consistently produced good results.
 Hypothermia    theoretically useful. – not proved
 TEMPERATURE           REDUCTION IS
  INDICATED.



In any field, find the strangest thing and explore it
Guide 11: (B) - OXYGENATION
   Hypoxia ( Moroney 1996) – Exacerbated by
    seizures Pneumonia and Arrhythmias - Worst
    outcome
   Oxygenation bas been Consistently useful.
   Hyperbaric O2 ineffective (Nighoghossaln
    1995)
   OXYGEN ADMINISTRATION IS
    USEFUL AND RECOMMENDED.

     He can’t walk and chew gum at the same time
Hyperglycemia
   DM & hyperglycemia are associated with
    larger infarcts and fasting hypoglycemia with
    smaller infarcts.
   Worsening in hyperglycemia is due to lactic
    acidosis
   Optimal blood glucose is less than 130 mg%
   Treat hyperglycemia with insulin.
          Take time to think; it is the source of power
        Take time to read; it is the foundation of wisdom
          Take time to work; it is the price of success
Guide: 12- Anti edema measures.
   Steroids are ineffective in stroke
   Mannitol, Glycerol, Hypertonic saline is
    useful in some cases.
   Loop diuretics are useful.
   Albumin can also be used – not proved in
    major trials
   Hyperventilation – useful for short periods,
    rebound edema is common- not
    recommended routinely.

          Thought is the labour of the intellect
                Reverie is its pleasure
Guide 13: (B) - OTHERS
   Haemodilution- Plasm Expanders
   TRIPLE – H therapy useful in SAH.
   Mean Arterial Pressure – 120-130 mm
    Hg
   CVP – 10-12 mm Hg
   PCWP –14-18mm Hg
   Hematocrit 30-33%
   Check ABG only if Hypoxia suspected.
Guide: 14 - OTHERS
   Barbiturate coma and propofol to reduce the
    elevated intracranial pressure have been
    useful in large ischaemic strokes.
   They produce hypotension and hence may be
    detrimental in some patients.
   Judicious use is advised.
   Indomethacin 50mg I.v. has been used in
    stroke to lower ICP – may reduce CBF- only
    case reports are available
Guide: 14 - OTHERS

   Sedation, pain control and neuromuscular
    blockade may be necessary in patients with
    altered sensorium as pain and irritation
    impede cerebral venous return
   Sedation reduces sympathetic overactivity,
    increases co operation for procedures and
    nursing care.
   Helpful in reducing the cerebral metabolism.
Guide 12: (B) - Blood Pressure
 Defer
      - acute reduction of BP - 10 days unless
 HT Encephalopathy or aortic dissection
 present
 Increase   in BP - falls in 10 days (Moris 1997)
 HT   - Prim. stroke prevention
 ACE-    I are very useful in managing HT
A   diuretic may also be combined.
 NO   DEFINITE LOWER LEVEL BP
Guide 13: (A/B) - AF
   AF / LV clot - warfarin after 48 Hrs – start
    along with heparin
   Aspirin for others
   EAFT 1995 Prothrombin time- Less than 2 -
    No effect
   PT- > 5 - Bleeding (SPAF 1996 )
Guide 15: Cholesterol
   Dietary and pharmacologic measures in
    reducing cholesterol are very effective
   Proven in large controlled trials
   Statins are very useful
   Start all patients with stroke on Statins.
               At twenty the will rules
                At thirty the intellect
                At forty the Judgment
Guide 16: Deep vein thrombosis

    50% stroke Pts –develop DVT 10 days (Kalra 1995
   Pulmonary embolism in 6-16% only (Sandercock 1993
    )
   Heparin 5000IU QID or 12500IU twice daily -
    Hemorrage greater
   Gradual stocking is of value -Use with caution - if
    peripheral artery insufficiency is present
   HEPARIN IS USEFUL IN PREVENTING DVT.
Guide 18: (A) –Antithrombotic
                drugs
   Aspirin 75 - 150 /Day
   3 yrs 40% reduces of vascular events in 1000
    pts (APTC - 1994)
   Stroke sub type value ? (TACI, PACI, LACI,
    POCI)
   synergy possible with clopidogrel ,ticlopidine
    etc.
Anti Coagulation
Warfarin - AF
   In sinus rhythm - uncertain
   Spirit 1997 low dose aspirin + Warfarin in TIA &
    Minorstorke
   Heparin (IST 1997) - Signif. reduction in early death (12
    fewor in 1000) not better than aspirin
   So avoid Heparin (A)
Guide 20: (I) Hemorrhage


   Supra tentorial evacuation for ICH is
    controversial - Avoid (Hankey and Hon 1997)
   Infra tentorial hematomas- early evacuation
   Main Indication - Deteriorating or depressed
    consciousness
Other measures.
   Nutritional maintenance especially if
    dysphagiais present
   Prevention of pulmonary complications
   Prevention/treatment of UTI
   Prevention of decubiti
   Treatment of depression
   Physiotherapy and rehabilitation
GOALS ACHIEVED ?
   Prevent first stroke
   Facilitate recovery
   improve neurological function
Dedicated to my family for
making everything worthwhile
READ not to contradict or confute
    Nor to Believe and Take for Granted
    but TO WEIGH AND CONSIDER


    THANK YOU
My sincere thanks to Mr. G. Kakuthan,

  for his meticulous computer work
DECISION
     TO USE THROMBOLYTIC




    NATURE, TIME AND PATIENCE
       are the 3 great physicians
DRUG - r tPA
       Before administering thrombolytic therapy
        the following investigations have to be
        carried out apart from the MANDATORY
        CT SCAN BRAIN which rules out
        hemorrhage.
       Routine blood biochemistry.
       Coagulation profile – PT,PTT
       Doppler studies.

The world shall perish not for lack of wonders but lack of wonder
Multimodal monitoring
   CBF monitoring –
              Xenon enhanced CT scanning
              laser doppler flowmetry (qualitative)
              Thermal diffusion ( quantitative)
   Brain tissue oxygenation
              tissue partial pressure of oxygen
    (Ptio2)
           Directly measured with electrodes.
       Through Action You Create your Own Education
                                    - D.B. ELLIS
Intracerebral microdialysis
   Monitor the chemistry of the
    extracellular space in living tissues.
   Physiological salt solution is slowly
    pumped through the microdialysis
    probe, the solution equilibrates with
    the surrounding extracellular tissue
    fluid.
   The microdialysate is then extracted
    and analysed for lactate and glutamate
     “Knowledge can be communicated but not Wisdom”
    etc..,
                                         - Hermann Hesse
Emergency Medical Care for Neurologic
              Emergencies

   •   Provide reassurance.
   •   Ensure proper airway and breathing.
   •   Place the patient in a position of comfort.
   •   Assess and care for any injuries if you
       suspect any type of trauma.


Many Ideas grow better when transplanted into another mind
           than in the one where they sprang UP
                                      O.W. Holmos
General management
   ABC
   Fluids & electrolytes
   Dysphagia, aspiration
   Urinary dysfunction
   Venous thromboembolism
   Seizures
   Skin care
   Depression
          Maintaining the right attitude is easier than
              regaining the right mental attitude
Management of acute ischemic stroke
   Systemic thrombolysis:
   Intravenous recombinant tissue plasminogen
    activator (rt-PA)
   Within 3 hrs of onset of stroke.
   Dose 0.9 mg/kg, max 90 mg.
   Intra arterial thrombolysis is being tried.-
    time window is upto 6 hrs. – technically
    demanding.
No Aspirin or heparin for 24 hrs. following
 thrombolysis
When they tell you to grow up, they mean stop growing
Management of acute ischemic stroke
                     (contd..)
   Anticoagulants: Heparin/LMWH NOT
    recommended in acute ischemic stroke routinely.
   Recommended in setting of atrial fibrillation,
    acute MI risk, prosthetic valves, coagulopathies
    and for prevention of DVT.
   Intra-arterial thrombolytics: An option for
    treatment of selected patients with major stroke
    of < 6 hrs duration due to large vessel occlusion.
             Why should I question the monkey
           when I can question the organ grinder?
Management of acute ischemic stroke
           (contd)- hypertension
   BP Should be kept within higher normal limits
    since low BP could precipitate perfusion failure.
   Reduction of BP in acute stroke phase is
    controversial.
   Reduce BP if there is severe end organ damage
    like pulmonary edema, encephalopathy, uremia.
    Markedly elevated BP (>220/110mmHg) managed
    with nitroglycerin, clonidine, labetalol, sodium
    nitroprusside.
   More aggressive approach is taken if thrombolytic
    therapy is instituted
       He is free who knows how to keep in his own hands
                    the power to decide
Management of acute ischemic stroke
           Glucose & pyrexia
   Blood glucose Should be kept within
    physiological levels using oral or IV
    glucose (in case of hypoglycemia)
   insulin (in case of hyperglycemia) RBS
    >300 mg
   Avoid routine glucose infusions
   Elevated body temperature
    management: Antipyretics and use of
    cooling device can improve the
    prognosis
           To get to the promised land you have to
          negotiate your way through the wilderness
Specific therapy - Ischaemic
   Thrombolytic therapy- r- tPA
   Time window – 3 hrs.
   0.9 mg/kg max. 90mg.
   10% bolus & 90% as infusion in 1 hour.
   Risk of hemorrage – 6%


It is a great misfortune not to possess sufficient wit to speak well
               nor sufficient judgment to keep silent
                                                    La Broyers character
Ancrod
          Venom of Malaysian pit viper.
          ↓Fibrinogen & viscosity
          ↓ RBC aggregation
          Endogenous tPA upregulation
          Vasodilatation
          Anticoagulant activity.

We possess by nature the factors out of which personality can be made, and to organize them
             into effective personal life is every man’s primary responsibility
                                                                  - Harry Emerson Fosdick
Hemorrheologic therapy
   Hemodilution
   Pentoxyfylline
   Ancrod – Malaysian pit viper venom.



       Mind is the great level of all things;
     human thought is the process by which
      human ends are ultimately answered
Thrombolytic drugs
   t NK- Tenectoplase – derived from t
    PA.
   Desmoteplase
   Alteplase
   r- pro UK
   Gp IIIa Iib receptor blockers.
   Lys- plasminogen
        “ Social Isolation is in itself a pathogenic
             Factor for disease production”
Secondary prevention of stroke
   Recurrence: Annual risk is 4.5 to 6%.
   Five year recurrence rates range from 24 to 42%
   one-third occur within first 30 days, hence high
    priority should be given to secondary prevention.
   Patients with TIA or stroke have an increased risk
    of MI or vascular event.
   Management of hypertension (goal <140/85 mm Hg)

                 A bad teacher complains;
                  A good teacher explains;
                 The best teacher inspires;
Secondary prevention of stroke

   Diabetes control (goal<126 mg/dL)
   Lipid management: Statins (goal
    cholesterol<200 mg/dL, LDL<100
    mg/dL)
   Anticoagulants: Warfarin (target INR 2
    to 3); esp. recommended in patients
    with cardioembolic stroke
   Appropriate life style modification
    (cessation of smoking, exercise, diet
    etc) Knowledge without action is useless;
          Action without knowledge is foolish
Secondary prevention of stroke
           Antiplatelet agents:
   Aspirin (50-325 mg),
   clopidogrel (75 mg).
   Ticlopidine 200mg bid
   Aspirin + ER Dipyridamole
   Sulfinpyrazone
   Suloctidil
   A combination of the two drug may also be
    used
Reputation is made in a moment; character is built in a life time
Complications of stroke
   Cerebral edema – 30% of patients
    worsen after stroke due to cerebral
    edema.
   24 – 96 hrs after acute stroke.
   Initially cytotoxic(gray matter),later
    vasogenic (white matter)
   Excitatory amino acids (EAA) –
    produces neurotoxic edema –
          Vedanta admits realization
    accelarates apoptosis.
          But defies verbal definition
Complications of ischaemic stroke
   Hemorrhagic transformation occurs in about
    40%.
   Occurs in first 2 weeks.
   10% of patients worsen.
   Increased risk with antithrombotics,
    anticoagulants, and thrombolytic therapy.
   Size (>1/3 rd) of the vascular territory and
    elderly are more prone for hemorrhagic
    transformation.
            Pure love ever gives; Never seeks
Management of Acute hemorrhagic
                stroke
   Analgesics/Antianxiety agents: To relieve
    headache. Analgesics having sedative
    properties are beneficial
   Hyperosmotic agents (e.g. mannitol,
    glycerol, furosemide): To reduce cerebral
    edema, and raised intracranial pressure.
   Adequate hydration is necessary
   Surgical intervention may occasionally be
    life saving
              What is mind no matter
             What is matter never mind
Surgical interventions
   Balloon angioplasty/stenting
   Carotid endarterectomy/Bypass
   Decompressive craniectomy
   Stem cell therapy.




    Every thing should be made as simple as possible;
                     but not simpler
Carotid endarterectomy & stenting
   CEA in symptomatic patients provides
    protection against stroke. ( >70% stenosis)
   In 50 –69% stenosis the benefit is marginal
    compared to medical therapy.
   The stroke reduction is realized early after
    surgery and persisted for extended periods.
   In TIA CEA has to be performed as early as
    possible if there is significant stenosis
   ECST and NASCET trials have proved the
    benefit.
     Hate screeches, fear squeals; conceits trumpets
                but love since lullabies
Carotid stenting & angioplasty
    “ FROM KNIFE TO STENT”
   In patients having a increased surgical
    risk.
   CCF, severe COPD, unstable angina,
    past radiation therapy, local tumor
    mass etc.,.
   SAPPHIRE study has shown benefit in
    a group of patients.
   Angioguardadapt, adjust and accommodate device is
            Learn to emboli protection
    used. to give, not to take and learn to serve not to rule
      Learn
Sub arachnoid hemorrhage (SAH)
   Aneurysmal or non aneurysmal.
   Vasospasm is a critical factor.
   Autoregulation impaired with
    vasospasm.
   Hunt and Hess grading – Clinical
   Fisher grading – CT scan
   Lumbar puncture may be necessary.
Teachers are reservoirs from which, through the process of
      education, the students draw the water of life
SAH - TRIPLE - H Therapy
   Hypertension
   Hypervolemia
   Hemodilution
   Nimodipine – used to treat vasospasm.




Love is selfishness and selfishness is lovelessness
SAH - Surgical
   Aneurysmal clipping within 48 – 72
    hours
   Prevents early rebleeding
   Permits aggressive therapy for
    vasospasm
   Endovascular therapy – coiling with
    GDC coils or thrombogenic platinum
    coils
   Asymptomatic one who thinks to his> 6mm
          Expert is aneurysms -
              chosen mode of ignorance
Number of events, fatal and nonfatal strokes and fatal and nonfatal
myocardial infarctions (MI) reported in recent prospective hypertension
                                  trials
       Trial            Average          Patients    Strokes     MI (n)
                           age         randomized        (n)
                         (years)           (n)
STOP-I                     76           1627            82        53
SHEP                       72           4736           269        165
STONE                      67           1632            52         4
Syst-Eur                   70           4695           124        78
Syst-China                 67           2394           104        16
HOT                        61           18790          294        209
CAPPP                      53           10985          340        327
STOP-2                     76           6614           452        293
NICS                       70            414            20         4
NORDIL                     60           1088           355        340
INSIGHT                    67           6575           1141       138
MODIFIABLE RISK FACTOR
Well documented risk factors
   Hypertension
   Cardiac diseases
        Atrial fibrillation
        Infective endocarditis
        Mitral stenosis
        Recent extensive myocardial infarction
   Cigarette smoking
   Transient ischemic attack
   Asymptomatic carotid stenosis
   Diabetes mellitus
   Hyperhomocystinemia
   Left ventricular hypertrohy
Less well documented risk factors

   Elevated blood cholesterol and         Spontaneous
    lipids                                  echocardiographic
   Cardiac disease                         contrast
        Cardiomyopathy
                                           Segmental well motion
                                            abnormalities
        Bacterial endocarditis
                                           Aortic stenosis
        Mitral annular calcification
                                           Patent foramen ovale
        Mitral valve prolapse
                                           Atrial septum aneurysm
        Valve strands

                A good teacher is a perpetual learner
   Use of oral contraceptives        Hypercoagulability and inflammation
   Consumption of alcohol                 Fibrin formation and fibrinolysis
   Use of illicit drugs                   Fibrinogen
   Physical inactivity                    Anticardiolipin antibodies
   Obesity                                Genetic and acquired causes
   Migraine                          Subclinical diseases
   Elevated hematocrit                    Carotid intima-media thickness
   Dietary factors                        Aortic atheroma
   Hyperinsulinemia and insulin           MRI evidence of infarct like
    resistance
                                            lesions
   Acute triggers (stress)           Socio economic features


       “ He who cannot forgive others destroy the bridge over
                                             s
               which he him m pass”- Annoy
                            self ust
Non modifiable risk factors
   Age
   Gender
   Hereditary / familial factors
   Race / ethnicity
   Geographic location



     It is not your position that makes you happy or unhappy
                      It is your disposition
Stroke incidence compared between
           antihypertensive drug trials
       Drug treatment            Relative risk         P
                                    (95% CI)
β-Blockers and/or diuretics vs   0.64 (0.41 – 0.90)   <0.01
placebo
ACEIs vs placebo                 0.70 (0.57 – 0.85)   <0.01
Calcium antagonists vs placebo   0.61 (0.44 – 0.85)   <0.01
ACEIs vs β-blockers and/or       1.05 (0.92 – 1.19)    NS
diuretics
Calcium antagonists vs β-        0.86 (0.76 – 0.98)    NS
blockers and/or diuretics
ACEIs vs calcium antagonists     1.02 (0.85 – 1.21)    NS
Control of risk factors
    Smoking cessation
    Reduction of alcohol consumption
    Physical exercise
    Dietary control
               Medical interventions
    Antihypertensive drug treatment
    Antithrombotic therapy
    Hypocholesterolemic drug treatment
    Antibiabetic and lipid-lowering treatment

    Let the wave of memory, the storm of desire, a fire of emotion pass
               through without affecting your equanimity
Stroke subtypes and risk factor associations
                                         Risk factor
Stroke           Age       HT     Smoking Diabete               AF     CHO
subtypes                                  s                            L
Ischemic          +++ ++               ++             ++         ++     +
Intracerebral     +++ +++               -              -          -     -
hemorrhage
Subarachnoid       ++       ++          -              -           -    -
hemorrhage


                 Learn to adapt, adjust and accommodate
           Learn to give, not to take and learn to serve not to rule
Ischemic stroke subtypes and risk factor
                     associations
                              Risk factor
Ischemic        Age   HT   Smoking Diabete   AF    CHO
Stroke                             s               L
subtypes
Artery-to-      +++   ++     ++       ++      -     +
artery
Lacunar         +++ +++      +++      ++      -     ±
Cardioembolic   +++ ++       ++       ++     +++    +
Aortic arch     +++ ++       ++       ++      -     +
Border zone     +++ ++       ++       ++      ±     +
Risk of thromboembolism in patients with
                    atrial fibrillation

      Clinical risk group            Thromboembolism rate
                                       per year (95% CI)
 No risk factors                             2.5 (1.3 – 5.0)
 One risk factor                            7.2 (4.8 – 10.8)
 Two or more risk factors                  17.6 (10.5 – 29.9)




Character gets y out of bed; com itm m
                ou                 m ent oves y to action faith, hope and
                                                  ou
                   Discipline follow through to completion
Recommendations for pre clinical evaluation
    of neuroprotectants in experimntal brain
                    ischemia
Drug dose    Generate dose-response curves in several
             species; assess likelihood of drug
             penetration of tissue at risk
Therapeutic    Assess carefully the time interval after the
time window    onset of ischemia or reperfusion when the
               drug can be successfully administered
Animal         Study permanent and transient ischemia
models         models initially in rats/mice, the possibly in
               cats or primates in a radomized and
               blinded fashion; results should be
               replicated by independent laboratories;
               consider influence of sex
Physiological   Monitor blood pressure, blood gases,
monitoring      hemoglobin, glucose, brain temperature and
                cerebral blood flow for as long as possible

Outcome         Evaluate acute and long-term outcome
measures        (typically reduced infarct volume). Assess
                functional recovery in multiple animal
                species

Target          It is uncertain if benefit in young, healthy
populations     animals can be extrapolated to elderly, sick
                humans
Combination     Consider using agents that affect multiple
therapy         mechanisms of neuronal injury after
                ischemia, simultaneously or in successions
                (the “cocktail” approach
Studies of moderate hypothermia after cardiac
                      arrest
     Study            Method          Favourable
                                           outcome (OR, 95
                                                 CI)

N Engl J Med 2002; N=77; 330C<2 hrs       5.25 (1.47-18.76)
346:549-556        after the return of
                   spontaneous            P = 0.011
                   circulation for 12 hrs

N Engl J Med 2002; N=27; 320C-340C for 1.4 (1.08-1.81)
346:557-563        24 hrs; median
                   interval between       P = 0.009
                   restoration of
                   circulation and
                   initiation of cooling;
                   105 min
GUIDELINES
History And Examination
                 Guide: 1 & 2
a.            Stroke clerking Performa (1994)
     R.C.P.
1.     Improved patient Assessment
2.      Improved Management & outcome- not
     clear


b.            Examination
1.     Secure Diagnosis of Stroke
2.     Specify Impairment
3. Identify sub type of Ischemic an audience
 God is a comedian performing before stroke
                that is afraid to laugh
Guide: 3               (B) - CPR

 –    Impaired consciousness in stroke is common in
     posterior circulation strokes.
 –     Impaired Consciousness - From Stroke
     Resuscitation is rarely successful -
     Schneider 1993




“Prediction is always difficult – especially when it concerns the future”
                                                    – Oscar Wilde
Guide: 4 - CXR

Chest x-ray abnormal in 16%
–    Only 4% change clinical management
–    Order x-ray chest if WT Loss or chest
    symptoms present
- Not recommended in routine stroke
   management.


If I were to choose between pain and nothing… I would choose pain
                                           -- William Faulkner
Guide: 5 - ECG
   Detection of cerebrogenic cardiovascular
    disturbance.
   Acute ST- T changes,rhythm abnormalities
    are common (upto 40%)
   Insular cortex involvement is an independent
    risk factor
   Rt. Sided lesions, age ,HT/DM/IHD are other
    factors
   Cardiac cause of Death (30 days)
   ALL STROKE PATIENTS TO HAVE ECG
    Pain is god’s greatest gift to mankind - Paul Brand.
Guide: 6 - ECHO
   To identify stroke mechanism.
   LV clot, Patent Foramen Ovale (PFO), Infective
    endocarditis, AF,Silent lesions
   Detects silent cardiac lesions
   Lesions of aorta
   TEE is more useful than TTE.
   High yield in ischaemic lesions.
   RECOMMENDED IN SETTINGS WHERE
    AVAILABLE and im oralityare two of the greatest inhibitors of
     The Truth is fear m
                        Performance to progress
Guide: 7 - CT scan brain
   ABSOLUTE INTEGRAL PART IN STROKE
   Differentiates between ischaemia, hemorrhage,
    SAH
   Early signs are useful in deciding about
    thrombolytic therapy. (Hyperdense MCA
    sign,insular ribbon sign,sulcal effacement)
   Helical and CT Angio are useful.
   MUST IN ALL STROKES
       Develop the heart; art comes automatically
Guide 8: M.R.I.

 Not   Routine in Acute Stroke
 Diffusion & perfusion weighted images are
 very useful in the acute phase in ischaemic
 infarction
 Along   with MRA gives valuable information
 NOT    ROUTINELY INDICATED

    “ My opinions are founded on knowledge
              but modified by experience”
Guide 9: - Doppler studies
   B-mode, Duplex, continuous wave and pulsed
    doppler systems, Color doppler flow imaging,
    TCD
   Shows changes in flow patterns near
    plaques.
   Gives idea about the vulnerability of the
    plaque.
   Useful in assessing the Vasospasm,
    collateral circulation, hemodynamic effects,
    reserve capacity
    To plan carotid endarterectomy.
   IUSEFUL peripheral neuritis– it interferes with work
      don’t like IN APPROPRIATE CLINICAL
Guide 10: (B) - FEVER
 Fever  (Worst Prog.) – 1 * C increases the
  metabolic need by 7% . Treatment of fever has
  consistently produced good results.
 Hypothermia    theoretically useful. – not proved
 TEMPERATURE           REDUCTION IS
  INDICATED.



In any field, find the strangest thing and explore it
Guide 11: (B) - OXYGENATION
   Hypoxia ( Moroney 1996) – Exacerbated by
    seizures Pneumonia and Arrhythmias - Worst
    outcome
   Oxygenation bas been Consistently useful.
   Hyperbaric O2 ineffective (Nighoghossaln
    1995)
   OXYGEN ADMINISTRATION IS
    USEFUL AND RECOMMENDED.

     He can’t walk and chew gum at the same time
Hyperglycemia
   DM & hyperglycemia are associated with
    larger infarcts and fasting hypoglycemia with
    smaller infarcts.
   Worsening in hyperglycemia is due to lactic
    acidosis
   Optimal blood glucose is less than 130 mg%
   Treat hyperglycemia with insulin.
          Take time to think; it is the source of power
        Take time to read; it is the foundation of wisdom
          Take time to work; it is the price of success
Guide: 12- Anti edema measures.
   Steroids are ineffective in stroke
   Mannitol, Glycerol, Hypertonic saline is
    useful in some cases.
   Loop diuretics are useful.
   Albumin can also be used – not proved in
    major trials
   Hyperventilation – useful for short periods,
    rebound edema is common- not
    recommended routinely.

          Thought is the labour of the intellect
                Reverie is its pleasure
Guide 13: (B) - OTHERS
   Haemodilution- Plasm Expanders
   TRIPLE – H therapy useful in SAH.
   Mean Arterial Pressure – 120-130 mm
    Hg
   CVP – 10-12 mm Hg
   PCWP –14-18mm Hg
   Hematocrit 30-33%
   Check ABG only if Hypoxia suspected.
Guide: 14 - OTHERS
   Barbiturate coma and propofol to reduce the
    elevated intracranial pressure have been
    useful in large ischaemic strokes.
   They produce hypotension and hence may be
    detrimental in some patients.
   Judicious use is advised.
   Indomethacin 50mg I.v. has been used in
    stroke to lower ICP – may reduce CBF- only
    case reports are available
Guide: 14 - OTHERS

   Sedation, pain control and neuromuscular
    blockade may be necessary in patients with
    altered sensorium as pain and irritation
    impede cerebral venous return
   Sedation reduces sympathetic overactivity,
    increases co operation for procedures and
    nursing care.
   Helpful in reducing the cerebral metabolism.
Guide 12: (B) - Blood Pressure
 Defer
      - acute reduction of BP - 10 days unless
 HT Encephalopathy or aortic dissection
 present
 Increase   in BP - falls in 10 days (Moris 1997)
 HT   - Prim. stroke prevention
 ACE-    I are very useful in managing HT
A   diuretic may also be combined.
 NO   DEFINITE LOWER LEVEL BP
Guide 13: (A/B) - AF
   AF / LV clot - warfarin after 48 Hrs – start
    along with heparin
   Aspirin for others
   EAFT 1995 Prothrombin time- Less than 2 -
    No effect
   PT- > 5 - Bleeding (SPAF 1996 )
Guide 15: Cholesterol
   Dietary and pharmacologic measures in
    reducing cholesterol are very effective
   Proven in large controlled trials
   Statins are very useful
   Start all patients with stroke on Statins.
               At twenty the will rules
                At thirty the intellect
                At forty the Judgment
Guide 16: Deep vein thrombosis

    50% stroke Pts –develop DVT 10 days (Kalra 1995
   Pulmonary embolism in 6-16% only (Sandercock 1993
    )
   Heparin 5000IU QID or 12500IU twice daily -
    Hemorrage greater
   Gradual stocking is of value -Use with caution - if
    peripheral artery insufficiency is present
   HEPARIN IS USEFUL IN PREVENTING DVT.
Guide 18: (A) –Antithrombotic
                drugs
   Aspirin 75 - 150 /Day
   3 yrs 40% reduces of vascular events in 1000
    pts (APTC - 1994)
   Stroke sub type value ? (TACI, PACI, LACI,
    POCI)
   synergy possible with clopidogrel ,ticlopidine
    etc.
Anti Coagulation
Warfarin - AF
   In sinus rhythm - uncertain
   Spirit 1997 low dose aspirin + Warfarin in TIA &
    Minorstorke
   Heparin (IST 1997) - Signif. reduction in early death (12
    fewor in 1000) not better than aspirin
   So avoid Heparin (A)
Guide 20: (I) Hemorrhage


   Supra tentorial evacuation for ICH is
    controversial - Avoid (Hankey and Hon 1997)
   Infra tentorial hematomas- early evacuation
   Main Indication - Deteriorating or depressed
    consciousness
Other measures.
   Nutritional maintenance especially if
    dysphagiais present
   Prevention of pulmonary complications
   Prevention/treatment of UTI
   Prevention of decubiti
   Treatment of depression
   Physiotherapy and rehabilitation
GOALS ACHIEVED ?
   Prevent first stroke
   Facilitate recovery
   improve neurological function
Dedicated to my family for
making everything worthwhile
READ not to contradict or confute
    Nor to Believe and Take for Granted
    but TO WEIGH AND CONSIDER


    THANK YOU
My sincere thanks to Mr. G. Kakuthan,

  for his meticulous computer work

Weitere ähnliche Inhalte

Andere mochten auch

Andere mochten auch (13)

Cerebrovascular disease2
Cerebrovascular disease2Cerebrovascular disease2
Cerebrovascular disease2
 
Virchow-Robin versus Lacunar Infarct CT & MRI
Virchow-Robin versus Lacunar Infarct CT & MRIVirchow-Robin versus Lacunar Infarct CT & MRI
Virchow-Robin versus Lacunar Infarct CT & MRI
 
Imaging of cerebral ischemia. 2014
Imaging of cerebral ischemia. 2014Imaging of cerebral ischemia. 2014
Imaging of cerebral ischemia. 2014
 
Stroke Community Presentation Guide[1]
Stroke Community Presentation Guide[1]Stroke Community Presentation Guide[1]
Stroke Community Presentation Guide[1]
 
Imaginginacutestroke dr anoop.k.r
Imaginginacutestroke dr anoop.k.rImaginginacutestroke dr anoop.k.r
Imaginginacutestroke dr anoop.k.r
 
Stroke
StrokeStroke
Stroke
 
Pediatric stroke radiology
Pediatric stroke radiologyPediatric stroke radiology
Pediatric stroke radiology
 
Imaging in acute stroke
Imaging in acute strokeImaging in acute stroke
Imaging in acute stroke
 
Imaging in ischemic stroke
Imaging in ischemic strokeImaging in ischemic stroke
Imaging in ischemic stroke
 
Basics of stroke(CVA) Management
Basics of stroke(CVA) ManagementBasics of stroke(CVA) Management
Basics of stroke(CVA) Management
 
QPR-Stroke
QPR-StrokeQPR-Stroke
QPR-Stroke
 
Pathology of Hypertension
Pathology of HypertensionPathology of Hypertension
Pathology of Hypertension
 
Stroke
StrokeStroke
Stroke
 

Ähnlich wie Management of stroke three to twenty four hours

mister light stroke
mister light strokemister light stroke
mister light strokeNour El-dien
 
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...Soujanya Pharm.D
 
stroke in ducks.pptx
stroke in ducks.pptxstroke in ducks.pptx
stroke in ducks.pptxDoctorThambi
 
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...Arlyn Valencia, M.D.
 
ISCHEMIC STROKE SYNDROMES AND MANAGEMENT.pptx
ISCHEMIC STROKE SYNDROMES AND MANAGEMENT.pptxISCHEMIC STROKE SYNDROMES AND MANAGEMENT.pptx
ISCHEMIC STROKE SYNDROMES AND MANAGEMENT.pptxMsigejb
 
approach to a patient with stroke.pdf
approach to a patient with stroke.pdfapproach to a patient with stroke.pdf
approach to a patient with stroke.pdfRajveer71
 
Pathology+of+stroke
Pathology+of+strokePathology+of+stroke
Pathology+of+strokeshabeel pn
 
strokeppt-170720174010.pdf
strokeppt-170720174010.pdfstrokeppt-170720174010.pdf
strokeppt-170720174010.pdfRiyaSharma295
 
Stroke in children
Stroke in childrenStroke in children
Stroke in childrenLm Huq
 
stroke 5th semestr final.pptx
stroke 5th semestr final.pptxstroke 5th semestr final.pptx
stroke 5th semestr final.pptxKomal Upreti
 
Stroke Assessment & Rehabilitation
Stroke Assessment & RehabilitationStroke Assessment & Rehabilitation
Stroke Assessment & RehabilitationHimani Kaushik
 
An Overview on Stroke & management
An Overview on Stroke & managementAn Overview on Stroke & management
An Overview on Stroke & managementDr. Imdadul Magfur
 
Degenerative diseases of brain (1)
Degenerative diseases of brain (1)Degenerative diseases of brain (1)
Degenerative diseases of brain (1)Khalaf Saba
 

Ähnlich wie Management of stroke three to twenty four hours (20)

mister light stroke
mister light strokemister light stroke
mister light stroke
 
Stroke_024211.pptx
Stroke_024211.pptxStroke_024211.pptx
Stroke_024211.pptx
 
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
 
stroke in ducks.pptx
stroke in ducks.pptxstroke in ducks.pptx
stroke in ducks.pptx
 
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
 
ISCHEMIC STROKE SYNDROMES AND MANAGEMENT.pptx
ISCHEMIC STROKE SYNDROMES AND MANAGEMENT.pptxISCHEMIC STROKE SYNDROMES AND MANAGEMENT.pptx
ISCHEMIC STROKE SYNDROMES AND MANAGEMENT.pptx
 
approach to a patient with stroke.pdf
approach to a patient with stroke.pdfapproach to a patient with stroke.pdf
approach to a patient with stroke.pdf
 
@ Stroke seminar
@ Stroke seminar@ Stroke seminar
@ Stroke seminar
 
Pathology+of+stroke
Pathology+of+strokePathology+of+stroke
Pathology+of+stroke
 
Ischemic Stroke
Ischemic StrokeIschemic Stroke
Ischemic Stroke
 
Stroke
StrokeStroke
Stroke
 
Stroke
StrokeStroke
Stroke
 
strokeppt-170720174010.pdf
strokeppt-170720174010.pdfstrokeppt-170720174010.pdf
strokeppt-170720174010.pdf
 
Stroke ppt
Stroke pptStroke ppt
Stroke ppt
 
Stroke in children
Stroke in childrenStroke in children
Stroke in children
 
stroke 5th semestr final.pptx
stroke 5th semestr final.pptxstroke 5th semestr final.pptx
stroke 5th semestr final.pptx
 
Stroke Assessment & Rehabilitation
Stroke Assessment & RehabilitationStroke Assessment & Rehabilitation
Stroke Assessment & Rehabilitation
 
An Overview on Stroke & management
An Overview on Stroke & managementAn Overview on Stroke & management
An Overview on Stroke & management
 
Stroke
StrokeStroke
Stroke
 
Degenerative diseases of brain (1)
Degenerative diseases of brain (1)Degenerative diseases of brain (1)
Degenerative diseases of brain (1)
 

Mehr von webzforu

Why controversies are of continuous relevance
Why controversies are of continuous relevanceWhy controversies are of continuous relevance
Why controversies are of continuous relevancewebzforu
 
When to start, switch or add in alzheimers disease memantine
When to start, switch or add in alzheimers disease memantineWhen to start, switch or add in alzheimers disease memantine
When to start, switch or add in alzheimers disease memantinewebzforu
 
Vertigo 2008
Vertigo 2008Vertigo 2008
Vertigo 2008webzforu
 
Vertigo 2010
Vertigo 2010Vertigo 2010
Vertigo 2010webzforu
 
Vertigo2010
Vertigo2010Vertigo2010
Vertigo2010webzforu
 
Vertigo and dizziness
Vertigo and dizzinessVertigo and dizziness
Vertigo and dizzinesswebzforu
 
Usa confirance
Usa confiranceUsa confirance
Usa confirancewebzforu
 
Unconscious sensory perception in a case of hemineglect
Unconscious sensory perception in a case of hemineglectUnconscious sensory perception in a case of hemineglect
Unconscious sensory perception in a case of hemineglectwebzforu
 
Three pronged approach to migraine epilepsy and neuropathic pain–role of oxca...
Three pronged approach to migraine epilepsy and neuropathic pain–role of oxca...Three pronged approach to migraine epilepsy and neuropathic pain–role of oxca...
Three pronged approach to migraine epilepsy and neuropathic pain–role of oxca...webzforu
 
Ten step approach to movement disorders
Ten step approach to movement disordersTen step approach to movement disorders
Ten step approach to movement disorderswebzforu
 
Stroke prevention a reality in this millennium
Stroke prevention a reality in this millenniumStroke prevention a reality in this millennium
Stroke prevention a reality in this millenniumwebzforu
 
Stroke and neuroprotection
Stroke and neuroprotectionStroke and neuroprotection
Stroke and neuroprotectionwebzforu
 
Sensory modulation in neurological rehabilitation
Sensory modulation in neurological rehabilitationSensory modulation in neurological rehabilitation
Sensory modulation in neurological rehabilitationwebzforu
 
Recovering repressed visual memories and in parietal lobe syndrome using vest...
Recovering repressed visual memories and in parietal lobe syndrome using vest...Recovering repressed visual memories and in parietal lobe syndrome using vest...
Recovering repressed visual memories and in parietal lobe syndrome using vest...webzforu
 
Recent advances in the mangement of extra pyramidal basal ganglia disorders
Recent advances in the mangement of extra pyramidal basal ganglia disorders Recent advances in the mangement of extra pyramidal basal ganglia disorders
Recent advances in the mangement of extra pyramidal basal ganglia disorders webzforu
 
Ragas dental college facical pain non odontogenic causes
Ragas dental college facical pain non odontogenic causesRagas dental college facical pain non odontogenic causes
Ragas dental college facical pain non odontogenic causeswebzforu
 
Practical algorithm for surgical management of facial pain
Practical algorithm for surgical management of facial painPractical algorithm for surgical management of facial pain
Practical algorithm for surgical management of facial painwebzforu
 
Pathophysiology of migraine
Pathophysiology of migrainePathophysiology of migraine
Pathophysiology of migrainewebzforu
 
Quality of life in post stroke patients-role of nootorpil
Quality of life in post stroke patients-role of nootorpilQuality of life in post stroke patients-role of nootorpil
Quality of life in post stroke patients-role of nootorpilwebzforu
 
Practice pearls diagnosis and prophylaxis of migraine
Practice pearls diagnosis and prophylaxis of migrainePractice pearls diagnosis and prophylaxis of migraine
Practice pearls diagnosis and prophylaxis of migrainewebzforu
 

Mehr von webzforu (20)

Why controversies are of continuous relevance
Why controversies are of continuous relevanceWhy controversies are of continuous relevance
Why controversies are of continuous relevance
 
When to start, switch or add in alzheimers disease memantine
When to start, switch or add in alzheimers disease memantineWhen to start, switch or add in alzheimers disease memantine
When to start, switch or add in alzheimers disease memantine
 
Vertigo 2008
Vertigo 2008Vertigo 2008
Vertigo 2008
 
Vertigo 2010
Vertigo 2010Vertigo 2010
Vertigo 2010
 
Vertigo2010
Vertigo2010Vertigo2010
Vertigo2010
 
Vertigo and dizziness
Vertigo and dizzinessVertigo and dizziness
Vertigo and dizziness
 
Usa confirance
Usa confiranceUsa confirance
Usa confirance
 
Unconscious sensory perception in a case of hemineglect
Unconscious sensory perception in a case of hemineglectUnconscious sensory perception in a case of hemineglect
Unconscious sensory perception in a case of hemineglect
 
Three pronged approach to migraine epilepsy and neuropathic pain–role of oxca...
Three pronged approach to migraine epilepsy and neuropathic pain–role of oxca...Three pronged approach to migraine epilepsy and neuropathic pain–role of oxca...
Three pronged approach to migraine epilepsy and neuropathic pain–role of oxca...
 
Ten step approach to movement disorders
Ten step approach to movement disordersTen step approach to movement disorders
Ten step approach to movement disorders
 
Stroke prevention a reality in this millennium
Stroke prevention a reality in this millenniumStroke prevention a reality in this millennium
Stroke prevention a reality in this millennium
 
Stroke and neuroprotection
Stroke and neuroprotectionStroke and neuroprotection
Stroke and neuroprotection
 
Sensory modulation in neurological rehabilitation
Sensory modulation in neurological rehabilitationSensory modulation in neurological rehabilitation
Sensory modulation in neurological rehabilitation
 
Recovering repressed visual memories and in parietal lobe syndrome using vest...
Recovering repressed visual memories and in parietal lobe syndrome using vest...Recovering repressed visual memories and in parietal lobe syndrome using vest...
Recovering repressed visual memories and in parietal lobe syndrome using vest...
 
Recent advances in the mangement of extra pyramidal basal ganglia disorders
Recent advances in the mangement of extra pyramidal basal ganglia disorders Recent advances in the mangement of extra pyramidal basal ganglia disorders
Recent advances in the mangement of extra pyramidal basal ganglia disorders
 
Ragas dental college facical pain non odontogenic causes
Ragas dental college facical pain non odontogenic causesRagas dental college facical pain non odontogenic causes
Ragas dental college facical pain non odontogenic causes
 
Practical algorithm for surgical management of facial pain
Practical algorithm for surgical management of facial painPractical algorithm for surgical management of facial pain
Practical algorithm for surgical management of facial pain
 
Pathophysiology of migraine
Pathophysiology of migrainePathophysiology of migraine
Pathophysiology of migraine
 
Quality of life in post stroke patients-role of nootorpil
Quality of life in post stroke patients-role of nootorpilQuality of life in post stroke patients-role of nootorpil
Quality of life in post stroke patients-role of nootorpil
 
Practice pearls diagnosis and prophylaxis of migraine
Practice pearls diagnosis and prophylaxis of migrainePractice pearls diagnosis and prophylaxis of migraine
Practice pearls diagnosis and prophylaxis of migraine
 

Kürzlich hochgeladen

Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 

Kürzlich hochgeladen (20)

Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 

Management of stroke three to twenty four hours

  • 1. The sign wasn’t placed there By the Big Printer in the sky Management of Stroke ( Three to Twenty Four Hours ) Prof.A.V.Srinivasan , M D, DM, Ph.D, DSc,F.R.C.P.(London) F.A.A.N, F.I.A.N Emeritus Professor, The Tamilnadu Dr.M.G.R.Medical university Former Professor and Head , INSTITUTE OF NEUROLOGY Madras Medical Colege
  • 2.
  • 3. OBJECTIVE  Definition  Stroke burden  Types & Mechanisms  Risk factors  Clinical evaluation  Investigations  Treatment of ischaemic stroke  Treatment of h hemorrhagic stroke & SAH  Rehabilitation  Newer developments – Interventions & neuroprotectives.
  • 4. Stroke: WHO Definition Stroke is clinically defined as a neurologic syndrome characterized by “Rapidly developing clinical signs of focal (at times global) disturbance of cerebral function, lasting more than 24 hours or leading to death with no apparent cause other than that of vascular origin”. CONCEPT OF “BRAIN ATTACK” In all of us, even in good men, there is a wild - beast nature which peers out in sleep
  • 5. Burden of Stroke  Most common life-threatening neurologic disease  Third most common cause of death globally  Incidence in India: 73/1,00,000 per year  No formal registry available.  Burden is likely to increase with risk factors like aging, smoking, adverse dietary patterns  Most common cause of disability and dependence.  70% of stroke survivors remaining vocationally impaired  30% requiring assistance with daily activities The True Art of Memory is The Art of Attention - S.Johnson
  • 6. Burden of Stroke  26 per lac per year  Ischaemic – 69%  Hemorragic –23%  SAH – 3%  Undetermined – 5% We learn by thinking and the quality of the learning outcome is determined by the quality of our thoughts R.B. Schmeck
  • 7. Types & mechanisms  Ischaemic – Atherothrombotic Embolic Lacunar  Hemorrhagic – ICH SAH  Global hypoperfusion – Watershed infarcts. A true commitment is a heart felt promise to yourself from which you will not back down - D. Mcnally
  • 8. Stroke: Classification Ischemic stroke: Account for 80%.  Results from occlusion in the blood vessel supplying the brain  Thrombotic: Occlusion due to atherothrombosis of small/large vessels supplying the brain  Embolic: Occlusion due to embolus arising either from heart (e.g. atrial fibrillation, valvular disease) or blood vessel Serious, sincere, systematic study surely secures supreme success
  • 9. Classification (contd.) Hemorrhagic stroke: Account for 20%. Results from rupture of blood vessels leading to bleeding in brain  Intracerebral: Bleeding within the brain due to rupture of small blood vessels. Occurs mainly due to high blood pressure  Subarachnoid: Bleeding around the brain; commonest cause is rupture of aneurysm.Other causes: Head injury Habit is either the best of servants or worst of masters
  • 10. LACUNAR INFARCT  <10mm in size.  Absence of cortical sings.  Super lacune >15mm.  Syndromes- ataxic hemiparesis  pure motor, pure sensory,sensory-motor  dysarthria clumsy hand, pure dysarthria,  hemichorea& unilateral asterixis. Success in life is a matter not so much of talent and opportunity as of concentration and perseverance - C.W. Wendte
  • 11. LACUNAR INFARCT  Associated with Systemic hypertension, DM  Weight of the heart exceeds 400g.  Prognosis -no mortality,  lenticulo striate territory-good recovery  ant.cho.artery-poor recovery. Give us the GR ACE to acce pt with se re nity the thing s that canno t be chang e d the COUR AGE to chang e the thing s that sho uld be chang e d and the WISDOM to kno w the diffe re nce
  • 12. Oxfordshire Community Stroke project (OCSP)  Anterior circulation stroke – Total (TACS)  Anterior circulation stroke – Partial (PACS)  Posterior circulation stroke – PCS  Lacunar Strokes.- (LS) “ He who cannot forgive others destroy the bridge over which he s him m pass” self ust - Annoy
  • 13. Differentials  Focal epilepsy.  Migraine.  Transient Global Amnesia.  Tumor  Metabolic Encephalopathy  Multiple Sclerosis. The secret of walking on water is Knowing where the stones are
  • 14. Transient Ischemic Attack (TIA)  “Mini stroke”  Stroke symptoms last for less than 24 hours (usually 10 to 15 mins)  Result as a brief interruption in blood flow to brain  Every TIA is an emergency  TIA may be a warning sign of a larger stroke  Patients with possible TIA should be evaluated If you think you can or you can’t You are always right
  • 15. TIA- contd  Few minutes to 24hrs (>85% within 30mts).  12% atherosclerotic infarct  Predominantly negative symptoms.  Weakness/numbness of UL/UL&LL,speech disturbance,mono ocular blindness, weakness of thumb&index the daughter of attention , Memory, finger. is the teeming mother of knowledge - Martin Tupper
  • 16. Stroke: Predisposing factors  Age (risk doubles for every decade after 55yrs)  Gender (males>females)  Family history of stroke/TIA  Hypertension  Diabetes  Hyperlipidemia  Hyperhomocysteinemia As long as you get there before It’s over you’re never late
  • 17. Stroke: Predisposing factors  Obesity  Smoking  Atrial fibrillation  Sedentary lifestyle  Drug abuse (e.g. cocaine use)  Hormone replacement therapy  Oral contraceptive Discipline Weighs ounces Regret weighs Tons
  • 18. Genetics & stroke  Single gene disorder Sickle cell disease Homocystinuria Marfans syndrome – dolichoectasia Fabry’s disease  Vascular risk factors Genetic hypercoagulable disorders Metabolic disorders with vasculopathy Hereditary intracranial aneurysms Some people feel the rain; Others just get wet
  • 19. Genetics & stroke  CADASIL – Cerebral Autosomal Dominant Arteriopathy with Subcortical infarcts and Leucoencephalopathy.  Recurrent episodes of subcortical infarcts or TIAs  Onset 30 – 50 years  Stroke, dementia, pseudobulbar palsy, migraine  MRI shows extensive leucoencephalopathy Opinion is ultimately determined by the feelings and not by the intellect
  • 20. Genetics & stroke  Multiple infarcts in the basal ganglia and in the periventricular regions .  U- fibers are spared.  Skin biopsy is diagnostic- granular, eosinophilic, electron dense material in the media of the arterial wall.  Familial clusters with hemiplegic migraine- CADASIL - M Experience can be defined as yesterday’s answer to today’s problems
  • 21. Stroke: Symptoms  Onset of stroke symptoms varies as per type of stroke  Thrombotic stroke: Develop more gradually  Embolic stroke: Hits suddenly  Hemorrhagic stroke: Hits suddenly and continues to worsen It is the province of the knowledge to speak and it is the privilege of the wisdomto listen - Hodly’s
  • 22. Stroke: Symptoms (contd.)  Dizziness  Confusion  Loss of balance/coordination  Nausea/vomiting  Numbness/weakness on one side of the body  Seizure  Severe headache  M ovement disorder/speech disorder/blindness etc (depending on the area of brain affected) Additional symptoms for hemorrhagic stroke  Pain upon looking at or into light  Painful stiff neck
  • 23. “SILENT STROKES” A silent stroke is a stroke which causes brain damage, but does not exhibit classic symptoms of stroke. They are detected only when a person undergoes a brain scan. – Multi infarct state. The meek shall inherit the earth - but not its mineral rights
  • 24. Stroke management “TIME IS BRAIN” Our best thoughts come from others
  • 25. Stroke management  Detection  Dispatch   Door Data 6 Ds  Decision  Drug It’s not over until it’s over
  • 26. DETECTION Success is a prize to be won. Action is the road to it. Chance is what may lurk in the shadows at the road side. - O. Henry
  • 27. Stroke management - Detection  Cincinatti stroke Score - Facial droop - Arm drift - Slurred speech 1 out of 3 - > 72% probability of stroke. Thinking is the hardest work there is, which is probable reason why so few engage in it. - Henry Ford
  • 28. Stroke management - Detection  Los Angeles Probable stroke Score. (LAPSS)  Includes arm drift, facial droop, slurring of spech, age , presence of risk factors like hypertension, DM, previous TIAs,  Little cumbersome.  No better than Cincinatti Score. People of mediocre ability often achieve success because they don’t know enough to quit - Bernard Baruch
  • 29. DISPATCH TO HOSPITAL EMR Whatever the Mind can conceive and Believe, the mind can Achieve Napoleon Hill
  • 30. Stroke management – to Door  On suspicion of stroke the person should be dispatched to the Emergency Medical Room as early as possible.( Within minutes)  Maintain vitals and arrange for transport.  No Aspirin or heparin to be administered. “ Social Isolation is in itself a pathogenic Factor for disease production”
  • 31.  DATA EMERGENCY IMAGING – CT/ MRI BIOCHEMICAL PROFILE Possible investigations. Science is below the mind; Spirituality is beyond the mind
  • 32. Stroke management – Door to data  Physical examination: Vitals,Neurologic  Brain imaging (cranial CT and/or MRI): discriminate between ischemic and hemorrhagic  Stroke Doppler ultrasonography/Angiography: Detect large vessel atherosclerosis  ECG/Echocardiography: Detect cardiac embolism  Exclusion of conditions mimicking stroke (hypoglycemia, migraine, seizure) Speak obligingly even if you cannot oblige
  • 33. Ischemic stroke diagnostic algorithm Acute focal brain deficit Excluded hypoglycemia, migraine with aura, post-seizure deficit < 1 hour TIA (if CT/MR brain imaging Head CT without ischemic lesion) Ischemic Stroke Lacunar syndrome Cortical syndrome Doppler MRI Vasculopathy CRYPTOGENIC MRA CT Coagulopathy STROKE ECG Angiogram Echo CARDIAC LARGE ARTERY SMALL OTHER DETERMINED EMBOLISM ATHEROSCLEROSIS VESSEL DISEASE CAUSE A woman’s desire for revenge outlasts all her other emotions
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41. General management  ABC  Fluids & electrolytes  Dysphagia, aspiration  Urinary dysfunction  Venous thromboembolism  Seizures  Skin care  Depression Maintaining the right attitude is easier than regaining the right mental attitude
  • 42. Management of acute ischemic stroke  Systemic thrombolysis:  Intravenous recombinant tissue plasminogen activator (rt-PA)  Within 3 hrs of onset of stroke.  Dose 0.9 mg/kg, max 90 mg.  Intra arterial thrombolysis is being tried.- time window is upto 6 hrs. – technically demanding. No Aspirin or heparin for 24 hrs. following thrombolysis When they tell you to grow up, they mean stop growing
  • 43. Management of acute ischemic stroke (contd..)  Anticoagulants: Heparin/LMWH NOT recommended in acute ischemic stroke routinely.  Recommended in setting of atrial fibrillation, acute MI risk, prosthetic valves, coagulopathies and for prevention of DVT.  Intra-arterial thrombolytics: An option for treatment of selected patients with major stroke of < 6 hrs duration due to large vessel occlusion. Why should I question the monkey when I can question the organ grinder?
  • 44. Management of acute ischemic stroke (contd)- hypertension  BP Should be kept within higher normal limits since low BP could precipitate perfusion failure.  Reduction of BP in acute stroke phase is controversial.  Reduce BP if there is severe end organ damage like pulmonary edema, encephalopathy, uremia.  Markedly elevated BP (>220/110mmHg) managed with nitroglycerin, clonidine, labetalol, sodium nitroprusside.  More aggressive approach is taken if thrombolytic therapy is instituted He is free who knows how to keep in his own hands the power to decide
  • 45. Management of acute ischemic stroke Glucose & pyrexia  Blood glucose Should be kept within physiological levels using oral or IV glucose (in case of hypoglycemia)  insulin (in case of hyperglycemia) RBS >300 mg  Avoid routine glucose infusions  Elevated body temperature management: Antipyretics and use of cooling device can improve the prognosis To get to the promised land you have to negotiate your way through the wilderness
  • 46. Specific therapy - Ischaemic  Thrombolytic therapy- r- tPA  Time window – 3 hrs.  0.9 mg/kg max. 90mg.  10% bolus & 90% as infusion in 1 hour.  Risk of hemorrage – 6% It is a great misfortune not to possess sufficient wit to speak well nor sufficient judgment to keep silent La Broyers character
  • 47. Ancrod  Venom of Malaysian pit viper.  ↓Fibrinogen & viscosity  ↓ RBC aggregation  Endogenous tPA upregulation  Vasodilatation  Anticoagulant activity. We possess by nature the factors out of which personality can be made, and to organize them into effective personal life is every man’s primary responsibility - Harry Emerson Fosdick
  • 48. Hemorrheologic therapy  Hemodilution  Pentoxyfylline  Ancrod – Malaysian pit viper venom. Mind is the great level of all things; human thought is the process by which human ends are ultimately answered
  • 49. Thrombolytic drugs  t NK- Tenectoplase – derived from t PA.  Desmoteplase  Alteplase  r- pro UK  Gp IIIa Iib receptor blockers.  Lys- plasminogen “ Social Isolation is in itself a pathogenic Factor for disease production”
  • 50. Secondary prevention of stroke  Recurrence: Annual risk is 4.5 to 6%.  Five year recurrence rates range from 24 to 42%  one-third occur within first 30 days, hence high priority should be given to secondary prevention.  Patients with TIA or stroke have an increased risk of MI or vascular event.  Management of hypertension (goal <140/85 mm Hg) A bad teacher complains; A good teacher explains; The best teacher inspires;
  • 51. Secondary prevention of stroke  Diabetes control (goal<126 mg/dL)  Lipid management: Statins (goal cholesterol<200 mg/dL, LDL<100 mg/dL)  Anticoagulants: Warfarin (target INR 2 to 3); esp. recommended in patients with cardioembolic stroke  Appropriate life style modification (cessation of smoking, exercise, diet etc) Knowledge without action is useless; Action without knowledge is foolish
  • 52. Secondary prevention of stroke Antiplatelet agents:  Aspirin (50-325 mg),  clopidogrel (75 mg).  Ticlopidine 200mg bid  Aspirin + ER Dipyridamole  Sulfinpyrazone  Suloctidil  A combination of the two drug may also be used Reputation is made in a moment; character is built in a life time
  • 53. Complications of stroke  Cerebral edema – 30% of patients worsen after stroke due to cerebral edema.  24 – 96 hrs after acute stroke.  Initially cytotoxic(gray matter),later vasogenic (white matter)  Excitatory amino acids (EAA) – produces neurotoxic edema – Vedanta admits realization accelarates apoptosis. But defies verbal definition
  • 54. Complications of ischaemic stroke  Hemorrhagic transformation occurs in about 40%.  Occurs in first 2 weeks.  10% of patients worsen.  Increased risk with antithrombotics, anticoagulants, and thrombolytic therapy.  Size (>1/3 rd) of the vascular territory and elderly are more prone for hemorrhagic transformation. Pure love ever gives; Never seeks
  • 55. Management of Acute hemorrhagic stroke  Analgesics/Antianxiety agents: To relieve headache. Analgesics having sedative properties are beneficial  Hyperosmotic agents (e.g. mannitol, glycerol, furosemide): To reduce cerebral edema, and raised intracranial pressure.  Adequate hydration is necessary  Surgical intervention may occasionally be life saving What is mind no matter What is matter never mind
  • 56. Surgical interventions  Balloon angioplasty/stenting  Carotid endarterectomy/Bypass  Decompressive craniectomy  Stem cell therapy. Every thing should be made as simple as possible; but not simpler
  • 57. Carotid endarterectomy & stenting  CEA in symptomatic patients provides protection against stroke. ( >70% stenosis)  In 50 –69% stenosis the benefit is marginal compared to medical therapy.  The stroke reduction is realized early after surgery and persisted for extended periods.  In TIA CEA has to be performed as early as possible if there is significant stenosis  ECST and NASCET trials have proved the benefit. Hate screeches, fear squeals; conceits trumpets but love since lullabies
  • 58. Carotid stenting & angioplasty “ FROM KNIFE TO STENT”  In patients having a increased surgical risk.  CCF, severe COPD, unstable angina, past radiation therapy, local tumor mass etc.,.  SAPPHIRE study has shown benefit in a group of patients.  Angioguardadapt, adjust and accommodate device is Learn to emboli protection used. to give, not to take and learn to serve not to rule Learn
  • 59. Sub arachnoid hemorrhage (SAH)  Aneurysmal or non aneurysmal.  Vasospasm is a critical factor.  Autoregulation impaired with vasospasm.  Hunt and Hess grading – Clinical  Fisher grading – CT scan  Lumbar puncture may be necessary. Teachers are reservoirs from which, through the process of education, the students draw the water of life
  • 60. SAH - TRIPLE - H Therapy  Hypertension  Hypervolemia  Hemodilution  Nimodipine – used to treat vasospasm. Love is selfishness and selfishness is lovelessness
  • 61. SAH - Surgical  Aneurysmal clipping within 48 – 72 hours  Prevents early rebleeding  Permits aggressive therapy for vasospasm  Endovascular therapy – coiling with GDC coils or thrombogenic platinum coils  Asymptomatic one who thinks to his> 6mm Expert is aneurysms - chosen mode of ignorance
  • 62.
  • 64. History And Examination Guide: 1 & 2 a. Stroke clerking Performa (1994) R.C.P. 1. Improved patient Assessment 2. Improved Management & outcome- not clear b. Examination 1. Secure Diagnosis of Stroke 2. Specify Impairment 3. Identify sub type of Ischemic an audience God is a comedian performing before stroke that is afraid to laugh
  • 65. Guide: 3 (B) - CPR – Impaired consciousness in stroke is common in posterior circulation strokes. – Impaired Consciousness - From Stroke Resuscitation is rarely successful - Schneider 1993 “Prediction is always difficult – especially when it concerns the future” – Oscar Wilde
  • 66. Guide: 4 - CXR Chest x-ray abnormal in 16% – Only 4% change clinical management – Order x-ray chest if WT Loss or chest symptoms present - Not recommended in routine stroke management. If I were to choose between pain and nothing… I would choose pain -- William Faulkner
  • 67. Guide: 5 - ECG  Detection of cerebrogenic cardiovascular disturbance.  Acute ST- T changes,rhythm abnormalities are common (upto 40%)  Insular cortex involvement is an independent risk factor  Rt. Sided lesions, age ,HT/DM/IHD are other factors  Cardiac cause of Death (30 days)  ALL STROKE PATIENTS TO HAVE ECG Pain is god’s greatest gift to mankind - Paul Brand.
  • 68. Guide: 6 - ECHO  To identify stroke mechanism.  LV clot, Patent Foramen Ovale (PFO), Infective endocarditis, AF,Silent lesions  Detects silent cardiac lesions  Lesions of aorta  TEE is more useful than TTE.  High yield in ischaemic lesions.  RECOMMENDED IN SETTINGS WHERE AVAILABLE and im oralityare two of the greatest inhibitors of The Truth is fear m Performance to progress
  • 69. Guide: 7 - CT scan brain  ABSOLUTE INTEGRAL PART IN STROKE  Differentiates between ischaemia, hemorrhage, SAH  Early signs are useful in deciding about thrombolytic therapy. (Hyperdense MCA sign,insular ribbon sign,sulcal effacement)  Helical and CT Angio are useful.  MUST IN ALL STROKES Develop the heart; art comes automatically
  • 70. Guide 8: M.R.I.  Not Routine in Acute Stroke  Diffusion & perfusion weighted images are very useful in the acute phase in ischaemic infarction  Along with MRA gives valuable information  NOT ROUTINELY INDICATED “ My opinions are founded on knowledge but modified by experience”
  • 71. Guide 9: - Doppler studies  B-mode, Duplex, continuous wave and pulsed doppler systems, Color doppler flow imaging, TCD  Shows changes in flow patterns near plaques.  Gives idea about the vulnerability of the plaque.  Useful in assessing the Vasospasm, collateral circulation, hemodynamic effects, reserve capacity  To plan carotid endarterectomy.  IUSEFUL peripheral neuritis– it interferes with work don’t like IN APPROPRIATE CLINICAL
  • 72. Guide 10: (B) - FEVER  Fever (Worst Prog.) – 1 * C increases the metabolic need by 7% . Treatment of fever has consistently produced good results.  Hypothermia theoretically useful. – not proved  TEMPERATURE REDUCTION IS INDICATED. In any field, find the strangest thing and explore it
  • 73. Guide 11: (B) - OXYGENATION  Hypoxia ( Moroney 1996) – Exacerbated by seizures Pneumonia and Arrhythmias - Worst outcome  Oxygenation bas been Consistently useful.  Hyperbaric O2 ineffective (Nighoghossaln 1995)  OXYGEN ADMINISTRATION IS USEFUL AND RECOMMENDED. He can’t walk and chew gum at the same time
  • 74. Hyperglycemia  DM & hyperglycemia are associated with larger infarcts and fasting hypoglycemia with smaller infarcts.  Worsening in hyperglycemia is due to lactic acidosis  Optimal blood glucose is less than 130 mg%  Treat hyperglycemia with insulin. Take time to think; it is the source of power Take time to read; it is the foundation of wisdom Take time to work; it is the price of success
  • 75. Guide: 12- Anti edema measures.  Steroids are ineffective in stroke  Mannitol, Glycerol, Hypertonic saline is useful in some cases.  Loop diuretics are useful.  Albumin can also be used – not proved in major trials  Hyperventilation – useful for short periods, rebound edema is common- not recommended routinely. Thought is the labour of the intellect Reverie is its pleasure
  • 76. Guide 13: (B) - OTHERS  Haemodilution- Plasm Expanders  TRIPLE – H therapy useful in SAH.  Mean Arterial Pressure – 120-130 mm Hg  CVP – 10-12 mm Hg  PCWP –14-18mm Hg  Hematocrit 30-33%  Check ABG only if Hypoxia suspected.
  • 77. Guide: 14 - OTHERS  Barbiturate coma and propofol to reduce the elevated intracranial pressure have been useful in large ischaemic strokes.  They produce hypotension and hence may be detrimental in some patients.  Judicious use is advised.  Indomethacin 50mg I.v. has been used in stroke to lower ICP – may reduce CBF- only case reports are available
  • 78. Guide: 14 - OTHERS  Sedation, pain control and neuromuscular blockade may be necessary in patients with altered sensorium as pain and irritation impede cerebral venous return  Sedation reduces sympathetic overactivity, increases co operation for procedures and nursing care.  Helpful in reducing the cerebral metabolism.
  • 79. Guide 12: (B) - Blood Pressure  Defer - acute reduction of BP - 10 days unless HT Encephalopathy or aortic dissection present  Increase in BP - falls in 10 days (Moris 1997)  HT - Prim. stroke prevention  ACE- I are very useful in managing HT A diuretic may also be combined.  NO DEFINITE LOWER LEVEL BP
  • 80. Guide 13: (A/B) - AF  AF / LV clot - warfarin after 48 Hrs – start along with heparin  Aspirin for others  EAFT 1995 Prothrombin time- Less than 2 - No effect  PT- > 5 - Bleeding (SPAF 1996 )
  • 81. Guide 15: Cholesterol  Dietary and pharmacologic measures in reducing cholesterol are very effective  Proven in large controlled trials  Statins are very useful  Start all patients with stroke on Statins. At twenty the will rules At thirty the intellect At forty the Judgment
  • 82. Guide 16: Deep vein thrombosis 50% stroke Pts –develop DVT 10 days (Kalra 1995  Pulmonary embolism in 6-16% only (Sandercock 1993 )  Heparin 5000IU QID or 12500IU twice daily - Hemorrage greater  Gradual stocking is of value -Use with caution - if peripheral artery insufficiency is present  HEPARIN IS USEFUL IN PREVENTING DVT.
  • 83. Guide 18: (A) –Antithrombotic drugs  Aspirin 75 - 150 /Day  3 yrs 40% reduces of vascular events in 1000 pts (APTC - 1994)  Stroke sub type value ? (TACI, PACI, LACI, POCI)  synergy possible with clopidogrel ,ticlopidine etc.
  • 84. Anti Coagulation Warfarin - AF  In sinus rhythm - uncertain  Spirit 1997 low dose aspirin + Warfarin in TIA & Minorstorke  Heparin (IST 1997) - Signif. reduction in early death (12 fewor in 1000) not better than aspirin  So avoid Heparin (A)
  • 85. Guide 20: (I) Hemorrhage  Supra tentorial evacuation for ICH is controversial - Avoid (Hankey and Hon 1997)  Infra tentorial hematomas- early evacuation  Main Indication - Deteriorating or depressed consciousness
  • 86. Other measures.  Nutritional maintenance especially if dysphagiais present  Prevention of pulmonary complications  Prevention/treatment of UTI  Prevention of decubiti  Treatment of depression  Physiotherapy and rehabilitation
  • 87. GOALS ACHIEVED ?  Prevent first stroke  Facilitate recovery  improve neurological function
  • 88.
  • 89.
  • 90. Dedicated to my family for making everything worthwhile
  • 91. READ not to contradict or confute Nor to Believe and Take for Granted but TO WEIGH AND CONSIDER THANK YOU My sincere thanks to Mr. G. Kakuthan, for his meticulous computer work
  • 92. DECISION TO USE THROMBOLYTIC NATURE, TIME AND PATIENCE are the 3 great physicians
  • 93. DRUG - r tPA  Before administering thrombolytic therapy the following investigations have to be carried out apart from the MANDATORY CT SCAN BRAIN which rules out hemorrhage.  Routine blood biochemistry.  Coagulation profile – PT,PTT  Doppler studies. The world shall perish not for lack of wonders but lack of wonder
  • 94. Multimodal monitoring  CBF monitoring – Xenon enhanced CT scanning laser doppler flowmetry (qualitative) Thermal diffusion ( quantitative)  Brain tissue oxygenation tissue partial pressure of oxygen (Ptio2) Directly measured with electrodes. Through Action You Create your Own Education - D.B. ELLIS
  • 95. Intracerebral microdialysis  Monitor the chemistry of the extracellular space in living tissues.  Physiological salt solution is slowly pumped through the microdialysis probe, the solution equilibrates with the surrounding extracellular tissue fluid.  The microdialysate is then extracted and analysed for lactate and glutamate “Knowledge can be communicated but not Wisdom” etc.., - Hermann Hesse
  • 96. Emergency Medical Care for Neurologic Emergencies • Provide reassurance. • Ensure proper airway and breathing. • Place the patient in a position of comfort. • Assess and care for any injuries if you suspect any type of trauma. Many Ideas grow better when transplanted into another mind than in the one where they sprang UP O.W. Holmos
  • 97. General management  ABC  Fluids & electrolytes  Dysphagia, aspiration  Urinary dysfunction  Venous thromboembolism  Seizures  Skin care  Depression Maintaining the right attitude is easier than regaining the right mental attitude
  • 98. Management of acute ischemic stroke  Systemic thrombolysis:  Intravenous recombinant tissue plasminogen activator (rt-PA)  Within 3 hrs of onset of stroke.  Dose 0.9 mg/kg, max 90 mg.  Intra arterial thrombolysis is being tried.- time window is upto 6 hrs. – technically demanding. No Aspirin or heparin for 24 hrs. following thrombolysis When they tell you to grow up, they mean stop growing
  • 99. Management of acute ischemic stroke (contd..)  Anticoagulants: Heparin/LMWH NOT recommended in acute ischemic stroke routinely.  Recommended in setting of atrial fibrillation, acute MI risk, prosthetic valves, coagulopathies and for prevention of DVT.  Intra-arterial thrombolytics: An option for treatment of selected patients with major stroke of < 6 hrs duration due to large vessel occlusion. Why should I question the monkey when I can question the organ grinder?
  • 100. Management of acute ischemic stroke (contd)- hypertension  BP Should be kept within higher normal limits since low BP could precipitate perfusion failure.  Reduction of BP in acute stroke phase is controversial.  Reduce BP if there is severe end organ damage like pulmonary edema, encephalopathy, uremia.  Markedly elevated BP (>220/110mmHg) managed with nitroglycerin, clonidine, labetalol, sodium nitroprusside.  More aggressive approach is taken if thrombolytic therapy is instituted He is free who knows how to keep in his own hands the power to decide
  • 101. Management of acute ischemic stroke Glucose & pyrexia  Blood glucose Should be kept within physiological levels using oral or IV glucose (in case of hypoglycemia)  insulin (in case of hyperglycemia) RBS >300 mg  Avoid routine glucose infusions  Elevated body temperature management: Antipyretics and use of cooling device can improve the prognosis To get to the promised land you have to negotiate your way through the wilderness
  • 102. Specific therapy - Ischaemic  Thrombolytic therapy- r- tPA  Time window – 3 hrs.  0.9 mg/kg max. 90mg.  10% bolus & 90% as infusion in 1 hour.  Risk of hemorrage – 6% It is a great misfortune not to possess sufficient wit to speak well nor sufficient judgment to keep silent La Broyers character
  • 103. Ancrod  Venom of Malaysian pit viper.  ↓Fibrinogen & viscosity  ↓ RBC aggregation  Endogenous tPA upregulation  Vasodilatation  Anticoagulant activity. We possess by nature the factors out of which personality can be made, and to organize them into effective personal life is every man’s primary responsibility - Harry Emerson Fosdick
  • 104. Hemorrheologic therapy  Hemodilution  Pentoxyfylline  Ancrod – Malaysian pit viper venom. Mind is the great level of all things; human thought is the process by which human ends are ultimately answered
  • 105. Thrombolytic drugs  t NK- Tenectoplase – derived from t PA.  Desmoteplase  Alteplase  r- pro UK  Gp IIIa Iib receptor blockers.  Lys- plasminogen “ Social Isolation is in itself a pathogenic Factor for disease production”
  • 106. Secondary prevention of stroke  Recurrence: Annual risk is 4.5 to 6%.  Five year recurrence rates range from 24 to 42%  one-third occur within first 30 days, hence high priority should be given to secondary prevention.  Patients with TIA or stroke have an increased risk of MI or vascular event.  Management of hypertension (goal <140/85 mm Hg) A bad teacher complains; A good teacher explains; The best teacher inspires;
  • 107. Secondary prevention of stroke  Diabetes control (goal<126 mg/dL)  Lipid management: Statins (goal cholesterol<200 mg/dL, LDL<100 mg/dL)  Anticoagulants: Warfarin (target INR 2 to 3); esp. recommended in patients with cardioembolic stroke  Appropriate life style modification (cessation of smoking, exercise, diet etc) Knowledge without action is useless; Action without knowledge is foolish
  • 108. Secondary prevention of stroke Antiplatelet agents:  Aspirin (50-325 mg),  clopidogrel (75 mg).  Ticlopidine 200mg bid  Aspirin + ER Dipyridamole  Sulfinpyrazone  Suloctidil  A combination of the two drug may also be used Reputation is made in a moment; character is built in a life time
  • 109. Complications of stroke  Cerebral edema – 30% of patients worsen after stroke due to cerebral edema.  24 – 96 hrs after acute stroke.  Initially cytotoxic(gray matter),later vasogenic (white matter)  Excitatory amino acids (EAA) – produces neurotoxic edema – Vedanta admits realization accelarates apoptosis. But defies verbal definition
  • 110. Complications of ischaemic stroke  Hemorrhagic transformation occurs in about 40%.  Occurs in first 2 weeks.  10% of patients worsen.  Increased risk with antithrombotics, anticoagulants, and thrombolytic therapy.  Size (>1/3 rd) of the vascular territory and elderly are more prone for hemorrhagic transformation. Pure love ever gives; Never seeks
  • 111. Management of Acute hemorrhagic stroke  Analgesics/Antianxiety agents: To relieve headache. Analgesics having sedative properties are beneficial  Hyperosmotic agents (e.g. mannitol, glycerol, furosemide): To reduce cerebral edema, and raised intracranial pressure.  Adequate hydration is necessary  Surgical intervention may occasionally be life saving What is mind no matter What is matter never mind
  • 112. Surgical interventions  Balloon angioplasty/stenting  Carotid endarterectomy/Bypass  Decompressive craniectomy  Stem cell therapy. Every thing should be made as simple as possible; but not simpler
  • 113. Carotid endarterectomy & stenting  CEA in symptomatic patients provides protection against stroke. ( >70% stenosis)  In 50 –69% stenosis the benefit is marginal compared to medical therapy.  The stroke reduction is realized early after surgery and persisted for extended periods.  In TIA CEA has to be performed as early as possible if there is significant stenosis  ECST and NASCET trials have proved the benefit. Hate screeches, fear squeals; conceits trumpets but love since lullabies
  • 114. Carotid stenting & angioplasty “ FROM KNIFE TO STENT”  In patients having a increased surgical risk.  CCF, severe COPD, unstable angina, past radiation therapy, local tumor mass etc.,.  SAPPHIRE study has shown benefit in a group of patients.  Angioguardadapt, adjust and accommodate device is Learn to emboli protection used. to give, not to take and learn to serve not to rule Learn
  • 115. Sub arachnoid hemorrhage (SAH)  Aneurysmal or non aneurysmal.  Vasospasm is a critical factor.  Autoregulation impaired with vasospasm.  Hunt and Hess grading – Clinical  Fisher grading – CT scan  Lumbar puncture may be necessary. Teachers are reservoirs from which, through the process of education, the students draw the water of life
  • 116. SAH - TRIPLE - H Therapy  Hypertension  Hypervolemia  Hemodilution  Nimodipine – used to treat vasospasm. Love is selfishness and selfishness is lovelessness
  • 117. SAH - Surgical  Aneurysmal clipping within 48 – 72 hours  Prevents early rebleeding  Permits aggressive therapy for vasospasm  Endovascular therapy – coiling with GDC coils or thrombogenic platinum coils  Asymptomatic one who thinks to his> 6mm Expert is aneurysms - chosen mode of ignorance
  • 118.
  • 119. Number of events, fatal and nonfatal strokes and fatal and nonfatal myocardial infarctions (MI) reported in recent prospective hypertension trials Trial Average Patients Strokes MI (n) age randomized (n) (years) (n) STOP-I 76 1627 82 53 SHEP 72 4736 269 165 STONE 67 1632 52 4 Syst-Eur 70 4695 124 78 Syst-China 67 2394 104 16 HOT 61 18790 294 209 CAPPP 53 10985 340 327 STOP-2 76 6614 452 293 NICS 70 414 20 4 NORDIL 60 1088 355 340 INSIGHT 67 6575 1141 138
  • 120. MODIFIABLE RISK FACTOR Well documented risk factors  Hypertension  Cardiac diseases  Atrial fibrillation  Infective endocarditis  Mitral stenosis  Recent extensive myocardial infarction  Cigarette smoking  Transient ischemic attack  Asymptomatic carotid stenosis  Diabetes mellitus  Hyperhomocystinemia  Left ventricular hypertrohy
  • 121. Less well documented risk factors  Elevated blood cholesterol and  Spontaneous lipids echocardiographic  Cardiac disease contrast  Cardiomyopathy  Segmental well motion abnormalities  Bacterial endocarditis  Aortic stenosis  Mitral annular calcification  Patent foramen ovale  Mitral valve prolapse  Atrial septum aneurysm  Valve strands A good teacher is a perpetual learner
  • 122. Use of oral contraceptives  Hypercoagulability and inflammation  Consumption of alcohol  Fibrin formation and fibrinolysis  Use of illicit drugs  Fibrinogen  Physical inactivity  Anticardiolipin antibodies  Obesity  Genetic and acquired causes  Migraine  Subclinical diseases  Elevated hematocrit  Carotid intima-media thickness  Dietary factors  Aortic atheroma  Hyperinsulinemia and insulin  MRI evidence of infarct like resistance lesions  Acute triggers (stress)  Socio economic features “ He who cannot forgive others destroy the bridge over s which he him m pass”- Annoy self ust
  • 123. Non modifiable risk factors  Age  Gender  Hereditary / familial factors  Race / ethnicity  Geographic location It is not your position that makes you happy or unhappy It is your disposition
  • 124. Stroke incidence compared between antihypertensive drug trials Drug treatment Relative risk P (95% CI) β-Blockers and/or diuretics vs 0.64 (0.41 – 0.90) <0.01 placebo ACEIs vs placebo 0.70 (0.57 – 0.85) <0.01 Calcium antagonists vs placebo 0.61 (0.44 – 0.85) <0.01 ACEIs vs β-blockers and/or 1.05 (0.92 – 1.19) NS diuretics Calcium antagonists vs β- 0.86 (0.76 – 0.98) NS blockers and/or diuretics ACEIs vs calcium antagonists 1.02 (0.85 – 1.21) NS
  • 125. Control of risk factors  Smoking cessation  Reduction of alcohol consumption  Physical exercise  Dietary control Medical interventions  Antihypertensive drug treatment  Antithrombotic therapy  Hypocholesterolemic drug treatment  Antibiabetic and lipid-lowering treatment Let the wave of memory, the storm of desire, a fire of emotion pass through without affecting your equanimity
  • 126. Stroke subtypes and risk factor associations Risk factor Stroke Age HT Smoking Diabete AF CHO subtypes s L Ischemic +++ ++ ++ ++ ++ + Intracerebral +++ +++ - - - - hemorrhage Subarachnoid ++ ++ - - - - hemorrhage Learn to adapt, adjust and accommodate Learn to give, not to take and learn to serve not to rule
  • 127. Ischemic stroke subtypes and risk factor associations Risk factor Ischemic Age HT Smoking Diabete AF CHO Stroke s L subtypes Artery-to- +++ ++ ++ ++ - + artery Lacunar +++ +++ +++ ++ - ± Cardioembolic +++ ++ ++ ++ +++ + Aortic arch +++ ++ ++ ++ - + Border zone +++ ++ ++ ++ ± +
  • 128. Risk of thromboembolism in patients with atrial fibrillation Clinical risk group Thromboembolism rate per year (95% CI) No risk factors 2.5 (1.3 – 5.0) One risk factor 7.2 (4.8 – 10.8) Two or more risk factors 17.6 (10.5 – 29.9) Character gets y out of bed; com itm m ou m ent oves y to action faith, hope and ou Discipline follow through to completion
  • 129. Recommendations for pre clinical evaluation of neuroprotectants in experimntal brain ischemia Drug dose Generate dose-response curves in several species; assess likelihood of drug penetration of tissue at risk Therapeutic Assess carefully the time interval after the time window onset of ischemia or reperfusion when the drug can be successfully administered Animal Study permanent and transient ischemia models models initially in rats/mice, the possibly in cats or primates in a radomized and blinded fashion; results should be replicated by independent laboratories; consider influence of sex
  • 130. Physiological Monitor blood pressure, blood gases, monitoring hemoglobin, glucose, brain temperature and cerebral blood flow for as long as possible Outcome Evaluate acute and long-term outcome measures (typically reduced infarct volume). Assess functional recovery in multiple animal species Target It is uncertain if benefit in young, healthy populations animals can be extrapolated to elderly, sick humans Combination Consider using agents that affect multiple therapy mechanisms of neuronal injury after ischemia, simultaneously or in successions (the “cocktail” approach
  • 131. Studies of moderate hypothermia after cardiac arrest Study Method Favourable outcome (OR, 95 CI) N Engl J Med 2002; N=77; 330C<2 hrs 5.25 (1.47-18.76) 346:549-556 after the return of spontaneous P = 0.011 circulation for 12 hrs N Engl J Med 2002; N=27; 320C-340C for 1.4 (1.08-1.81) 346:557-563 24 hrs; median interval between P = 0.009 restoration of circulation and initiation of cooling; 105 min
  • 132.
  • 133.
  • 134.
  • 135.
  • 136.
  • 137.
  • 138.
  • 139.
  • 140.
  • 141.
  • 142.
  • 143.
  • 144.
  • 145.
  • 147. History And Examination Guide: 1 & 2 a. Stroke clerking Performa (1994) R.C.P. 1. Improved patient Assessment 2. Improved Management & outcome- not clear b. Examination 1. Secure Diagnosis of Stroke 2. Specify Impairment 3. Identify sub type of Ischemic an audience God is a comedian performing before stroke that is afraid to laugh
  • 148. Guide: 3 (B) - CPR – Impaired consciousness in stroke is common in posterior circulation strokes. – Impaired Consciousness - From Stroke Resuscitation is rarely successful - Schneider 1993 “Prediction is always difficult – especially when it concerns the future” – Oscar Wilde
  • 149. Guide: 4 - CXR Chest x-ray abnormal in 16% – Only 4% change clinical management – Order x-ray chest if WT Loss or chest symptoms present - Not recommended in routine stroke management. If I were to choose between pain and nothing… I would choose pain -- William Faulkner
  • 150. Guide: 5 - ECG  Detection of cerebrogenic cardiovascular disturbance.  Acute ST- T changes,rhythm abnormalities are common (upto 40%)  Insular cortex involvement is an independent risk factor  Rt. Sided lesions, age ,HT/DM/IHD are other factors  Cardiac cause of Death (30 days)  ALL STROKE PATIENTS TO HAVE ECG Pain is god’s greatest gift to mankind - Paul Brand.
  • 151. Guide: 6 - ECHO  To identify stroke mechanism.  LV clot, Patent Foramen Ovale (PFO), Infective endocarditis, AF,Silent lesions  Detects silent cardiac lesions  Lesions of aorta  TEE is more useful than TTE.  High yield in ischaemic lesions.  RECOMMENDED IN SETTINGS WHERE AVAILABLE and im oralityare two of the greatest inhibitors of The Truth is fear m Performance to progress
  • 152. Guide: 7 - CT scan brain  ABSOLUTE INTEGRAL PART IN STROKE  Differentiates between ischaemia, hemorrhage, SAH  Early signs are useful in deciding about thrombolytic therapy. (Hyperdense MCA sign,insular ribbon sign,sulcal effacement)  Helical and CT Angio are useful.  MUST IN ALL STROKES Develop the heart; art comes automatically
  • 153. Guide 8: M.R.I.  Not Routine in Acute Stroke  Diffusion & perfusion weighted images are very useful in the acute phase in ischaemic infarction  Along with MRA gives valuable information  NOT ROUTINELY INDICATED “ My opinions are founded on knowledge but modified by experience”
  • 154. Guide 9: - Doppler studies  B-mode, Duplex, continuous wave and pulsed doppler systems, Color doppler flow imaging, TCD  Shows changes in flow patterns near plaques.  Gives idea about the vulnerability of the plaque.  Useful in assessing the Vasospasm, collateral circulation, hemodynamic effects, reserve capacity  To plan carotid endarterectomy.  IUSEFUL peripheral neuritis– it interferes with work don’t like IN APPROPRIATE CLINICAL
  • 155. Guide 10: (B) - FEVER  Fever (Worst Prog.) – 1 * C increases the metabolic need by 7% . Treatment of fever has consistently produced good results.  Hypothermia theoretically useful. – not proved  TEMPERATURE REDUCTION IS INDICATED. In any field, find the strangest thing and explore it
  • 156. Guide 11: (B) - OXYGENATION  Hypoxia ( Moroney 1996) – Exacerbated by seizures Pneumonia and Arrhythmias - Worst outcome  Oxygenation bas been Consistently useful.  Hyperbaric O2 ineffective (Nighoghossaln 1995)  OXYGEN ADMINISTRATION IS USEFUL AND RECOMMENDED. He can’t walk and chew gum at the same time
  • 157. Hyperglycemia  DM & hyperglycemia are associated with larger infarcts and fasting hypoglycemia with smaller infarcts.  Worsening in hyperglycemia is due to lactic acidosis  Optimal blood glucose is less than 130 mg%  Treat hyperglycemia with insulin. Take time to think; it is the source of power Take time to read; it is the foundation of wisdom Take time to work; it is the price of success
  • 158. Guide: 12- Anti edema measures.  Steroids are ineffective in stroke  Mannitol, Glycerol, Hypertonic saline is useful in some cases.  Loop diuretics are useful.  Albumin can also be used – not proved in major trials  Hyperventilation – useful for short periods, rebound edema is common- not recommended routinely. Thought is the labour of the intellect Reverie is its pleasure
  • 159. Guide 13: (B) - OTHERS  Haemodilution- Plasm Expanders  TRIPLE – H therapy useful in SAH.  Mean Arterial Pressure – 120-130 mm Hg  CVP – 10-12 mm Hg  PCWP –14-18mm Hg  Hematocrit 30-33%  Check ABG only if Hypoxia suspected.
  • 160. Guide: 14 - OTHERS  Barbiturate coma and propofol to reduce the elevated intracranial pressure have been useful in large ischaemic strokes.  They produce hypotension and hence may be detrimental in some patients.  Judicious use is advised.  Indomethacin 50mg I.v. has been used in stroke to lower ICP – may reduce CBF- only case reports are available
  • 161. Guide: 14 - OTHERS  Sedation, pain control and neuromuscular blockade may be necessary in patients with altered sensorium as pain and irritation impede cerebral venous return  Sedation reduces sympathetic overactivity, increases co operation for procedures and nursing care.  Helpful in reducing the cerebral metabolism.
  • 162. Guide 12: (B) - Blood Pressure  Defer - acute reduction of BP - 10 days unless HT Encephalopathy or aortic dissection present  Increase in BP - falls in 10 days (Moris 1997)  HT - Prim. stroke prevention  ACE- I are very useful in managing HT A diuretic may also be combined.  NO DEFINITE LOWER LEVEL BP
  • 163. Guide 13: (A/B) - AF  AF / LV clot - warfarin after 48 Hrs – start along with heparin  Aspirin for others  EAFT 1995 Prothrombin time- Less than 2 - No effect  PT- > 5 - Bleeding (SPAF 1996 )
  • 164. Guide 15: Cholesterol  Dietary and pharmacologic measures in reducing cholesterol are very effective  Proven in large controlled trials  Statins are very useful  Start all patients with stroke on Statins. At twenty the will rules At thirty the intellect At forty the Judgment
  • 165. Guide 16: Deep vein thrombosis 50% stroke Pts –develop DVT 10 days (Kalra 1995  Pulmonary embolism in 6-16% only (Sandercock 1993 )  Heparin 5000IU QID or 12500IU twice daily - Hemorrage greater  Gradual stocking is of value -Use with caution - if peripheral artery insufficiency is present  HEPARIN IS USEFUL IN PREVENTING DVT.
  • 166. Guide 18: (A) –Antithrombotic drugs  Aspirin 75 - 150 /Day  3 yrs 40% reduces of vascular events in 1000 pts (APTC - 1994)  Stroke sub type value ? (TACI, PACI, LACI, POCI)  synergy possible with clopidogrel ,ticlopidine etc.
  • 167. Anti Coagulation Warfarin - AF  In sinus rhythm - uncertain  Spirit 1997 low dose aspirin + Warfarin in TIA & Minorstorke  Heparin (IST 1997) - Signif. reduction in early death (12 fewor in 1000) not better than aspirin  So avoid Heparin (A)
  • 168. Guide 20: (I) Hemorrhage  Supra tentorial evacuation for ICH is controversial - Avoid (Hankey and Hon 1997)  Infra tentorial hematomas- early evacuation  Main Indication - Deteriorating or depressed consciousness
  • 169. Other measures.  Nutritional maintenance especially if dysphagiais present  Prevention of pulmonary complications  Prevention/treatment of UTI  Prevention of decubiti  Treatment of depression  Physiotherapy and rehabilitation
  • 170. GOALS ACHIEVED ?  Prevent first stroke  Facilitate recovery  improve neurological function
  • 171.
  • 172.
  • 173. Dedicated to my family for making everything worthwhile
  • 174. READ not to contradict or confute Nor to Believe and Take for Granted but TO WEIGH AND CONSIDER THANK YOU My sincere thanks to Mr. G. Kakuthan, for his meticulous computer work